{"uri":"/api/components/2991","count":47,"data":[{"Synonyms":["LIOTRIX (T4;T3) [ORANGE BOOK]","LIOTRIX [USP]","LIOTRIX [USAN]","THYROLAR","EUTHROID","A MIXTURE OF LIOTHYRONINE SODIUM AND LEVOTHYROXINE SODIUM, IN A RATIO OF 1:1 IN TERMS OF BIOLOGICAL ACTIVITY, OR IN A RATIO OF 1:4 IN TERMS OF WEIGHT","LIOTRIX","LIOTRIX (T4;T3)"],"ActiveMoieties":"YW8HJ0N26X","NDF-RT":["N0000006165","N0000007632","N0000175945","N0000175946"],"LactMed":"8065-29-0","CAS":"8065-29-0","DRUG BANK":"DB01583","References":["WEBSITE","LIOTRIX (T4;T3) [ORANGE BOOK]","LIOTRIX [USP]","LIOTRIX [USAN]","SRS import [YW8HJ0N26X]","SRS CODE IMPORT","ORANGE BOOK 2011","USP 33","USP DICTIONARY 2011","USP DICTIONARY 2010","USP DICTIONARY 2009","ORANGE BOOOK"],"NCI_THESAURUS":"C87251","ChEMBL":["CHEMBL559","CHEMBL1544"],"Class":"mixture","id":"YW8HJ0N26X","PreferredName":"LIOTRIX","UNII":"YW8HJ0N26X"},{"EVMPD":["SUB127246","SUB02917MIG"],"WHO-ESSENTIAL MEDICINES LIST":["18.8"],"ActiveMoieties":["Q51BO43MG4"],"ECHA (EC/EINECS)":["200-101-1"],"WHO-ATC":["H03AA03"],"MESH":["D013974"],"CFR":["21 CFR 520.1248","21 CFR 862.1700","21 CFR 862.1695","21 CFR 862.1685"],"MERCK INDEX":["M10840"],"WIKIPEDIA":["LEVOTHYROXINE"],"NCI_THESAURUS":["C62080"],"ChEMBL":["CHEMBL1624"],"PreferredName":["LEVOTHYROXINE"],"id":"Q51BO43MG4","WHO-VATC":["QH03AA03"],"UNII":["Q51BO43MG4"],"Synonyms":["LEVOTHYROXINE [WHO-DD]","LEVOTHYROXINE [USP-RS]","3,5,3',5'-TETRAIODO-L-THYRONINE","LEVOTHYROXINE [HSDB]","SYNTHETIC LEVOTHYROXINE","THYROXINE [MI]","(-)-3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE","THYROXINE, L-","L-THYROXINE","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-","O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-L-TYROSINE","THYROXINE","SK&F 1-6528","NSC-36397","LEVOTHYROXINE [VANDF]","LEVOTHYROXINE"],"LIVERTOX":["958"],"NDF-RT":["N0000007632","N0000175945"],"HSDB":["51-48-9"],"SMILES":"N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","LactMed":["51-48-9"],"IUPHAR":["2635"],"CAS":["51-48-9"],"DRUG BANK":["DB00451"],"References":["WEBSITE","WEBSITE","WEBSITE","LEVOTHYROXINE [VANDF]","LEVOTHYROXINE [WHO-DD]","LEVOTHYROXINE [USP-RS]","LEVOTHYROXINE [HSDB]","THYROXINE [MI]","USP Dictionary 2010","SRS import [Q51BO43MG4]","THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM AUGUST 1, 2005 VOL. 90 NO. 8 4946-4954","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc","SRS CODE IMPORT","SCIFINDER","NDF-RT","usp","WHO-DD","USP/NF","HSDB","rxnorm","MERCK INDEX","FDA_SRS","USP DICTIONARY 2009","Merck","MERCK"],"EPA CompTox":["51-48-9"],"MOLFILE":"Q51BO43MG4\n  Marvin  11101716382D          \n\n 24 25  0  0  1  0            999 V2000\n    6.4250   -6.2772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1258   -5.8660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8312   -6.2491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8312   -7.1040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1398   -7.4824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4250   -7.0760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.6870   -7.5104    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5459   -7.5104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2606   -7.1040    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    9.9754   -7.5385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.9754   -8.3466    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   10.7041   -7.1320    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2606   -6.2912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1258   -4.8337    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    5.6963   -5.8660    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    4.9956   -6.2491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.9956   -7.0760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2856   -7.5057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2856   -8.3373    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5661   -7.1040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5661   -6.2725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2716   -5.8427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8421   -5.8660    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8421   -7.5150    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  2  1  0  0  0  0\n  3  4  2  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7  6  1  0  0  0  0\n  8  4  1  0  0  0  0\n  9  8  1  0  0  0  0\n 10  9  1  0  0  0  0\n 11 10  2  0  0  0  0\n 12 10  1  0  0  0  0\n  9 13  1  6  0  0  0\n 14  2  1  0  0  0  0\n 15  1  1  0  0  0  0\n 16 15  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  2  0  0  0  0\n 19 18  1  0  0  0  0\n 18 20  1  0  0  0  0\n 20 21  2  0  0  0  0\n 21 22  1  0  0  0  0\n 22 16  2  0  0  0  0\n 23 21  1  0  0  0  0\n 24 20  1  0  0  0  0\nM  END\n","name":"Q51BO43MG4","RXCUI":["10582"]},{"EVMPD":["SUB08527MIG"],"ActiveMoieties":["06LU7C9H1V"],"ECHA (EC/EINECS)":["229-999-3"],"WHO-ATC":["H03AA03"],"INN":["653"],"MESH":["D014284"],"CFR":["21 CFR 520.1284","21 CFR 862.1715","21 CFR 862.1710"],"MERCK INDEX":["M6835"],"WIKIPEDIA":["LIOTHYRONINE"],"NCI_THESAURUS":["C907"],"ChEMBL":["CHEMBL1544"],"PreferredName":["LIOTHYRONINE"],"id":"06LU7C9H1V","WHO-VATC":["QH03AA03"],"UNII":["06LU7C9H1V"],"Synonyms":["3,5,3'-TRIIODOTHYRONINE","RATHYRONINE, (S)-","NSC-80203","CYRONINE","3,3',5-TRIIODO-L-THYRONINE","THYRONINE, 3,3',5-TRIIODO-, L-","ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, L-","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-","LIOTHYRONINE [VANDF]","LEVOTHYROXINE SODIUM IMPURITY, LIOTHYRONINE- [USP]","LEVOTHYROXINE SODIUM SPECIFIED IMPURITY A [EP]","LIOTHYRONINE [WHO-DD]","LIOTHYRONINE [USP-RS]","LIOTHYRONINE [HSDB]","LIOTHYRONINE [MI]","LIOTHYRONINE [INN]","O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-L-TYROSINE","TRIIODOTHYRONINE","LIOTHYRONINE","3,5,3'-TRIIODOTHYRONINE, L-"],"LIVERTOX":["1000"],"NDF-RT":["N0000175946","N0000006165","N0000006165"],"HSDB":["6893-02-3"],"SMILES":"N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O","LactMed":["6893-02-3"],"IUPHAR":["2634"],"CAS":["6893-02-3"],"DRUG BANK":["DB00279"],"References":["WEBSITE","WEBSITE","WEBSITE","LIOTHYRONINE [VANDF]","LIOTHYRONINE [WHO-DD]","LIOTHYRONINE [USP-RS]","LIOTHYRONINE [HSDB]","LIOTHYRONINE [MI]","LIOTHYRONINE [INN]","SRS import [06LU7C9H1V]","SRS CODE IMPORT","TOX 21","STN","FDA","NDF-RT","EP","WHO-DD","USP/NF","HSDB","MERCK INDEX","INN 2010","WIKEPEDIA","USP Dictionary 2010","MERCK"],"EPA CompTox":["6893-02-3"],"MOLFILE":"06LU7C9H1V\n  Marvin  11101716382D          \n\n 23 24  0  0  1  0            999 V2000\n   -1.8191    2.0635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.5386    2.4662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.8327    1.2308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -5.3849    0.8235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.1132    2.4662    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -3.2627    1.2444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.3032    0.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.3891    1.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -4.6745    1.2308    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   -3.2535    2.0545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.5612    0.8235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.4027    2.0545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -3.9730    0.8055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.0227    1.2535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -5.3985   -0.0046    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    1.0091    2.0861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.5250    3.3124    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.0906    0.8055    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.3212    0.0181    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -4.6835    2.0680    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   -6.0999    1.2308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.2987    2.4889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.7512    0.8553    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  1  1  0  0  0  0\n  4  9  1  0  0  0  0\n  5  1  1  0  0  0  0\n  6 11  1  0  0  0  0\n  7  8  2  0  0  0  0\n  8 12  1  0  0  0  0\n  9 13  1  0  0  0  0\n 10  2  1  0  0  0  0\n 11  3  2  0  0  0  0\n 12  5  1  0  0  0  0\n 13  6  1  0  0  0  0\n 14 16  2  0  0  0  0\n 15  4  2  0  0  0  0\n 16 22  1  0  0  0  0\n 17  2  1  0  0  0  0\n 18  3  1  0  0  0  0\n 19  7  1  0  0  0  0\n  9 20  1  1  0  0  0\n 21  4  1  0  0  0  0\n 22 12  2  0  0  0  0\n 23 14  1  0  0  0  0\n  6 10  2  0  0  0  0\n  7 14  1  0  0  0  0\nM  END\n","name":"06LU7C9H1V","RXCUI":["10814"]},{"Synonyms":["DEXTROTHYROXINE SODIUM [VANDF]","THYROXINE, MONOSODIUM SALT, HYDRATE, D-","DEXTROTHYROXINE SODIUM HYDRATE [MART.]","DEXTROTHYROXINE SODIUM HYDRATE","DEXTROTHYROXINE SODIUM [MART.]","DEXTROTHYROXINE SODIUM [ORANGE BOOK]","DEXTROTHYROXINE SODIUM [USAN]","CHOLOXIN","MONOSODIUM D-THYROXINE HYDRATE","D-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT, HYDRATE","DEXTROTHYROXINE SODIUM"],"ActiveMoieties":["4W9K63FION"],"SMILES":"O.[Na+].N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O","CAS":["7054-08-2"],"References":["WEBSITE","DEXTROTHYROXINE SODIUM [VANDF]","DEXTROTHYROXINE SODIUM HYDRATE [MART.]","DEXTROTHYROXINE SODIUM [MART.]","DEXTROTHYROXINE SODIUM [ORANGE BOOK]","DEXTROTHYROXINE SODIUM [USAN]","SRS import [0H00N2AHSP]","SRS CODE IMPORT","NDF-RT","STN","MARTINDALE","MARTINDALE 2011","ORANGE BOOK 2011","USP DICTIONARY 2011","USP DICTIONARY 2010","USP Dictionary 2010"],"MOLFILE":"0H00N2AHSP\n  Marvin  11101716412D          \n\n 26 25  0  0  1  0            999 V2000\n   14.2477   -9.7809    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   19.9804   -8.0631    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n   13.2754   -7.0232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.9905   -6.6118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.7197   -6.9952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.6964   -7.8505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.0046   -8.2291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.2894   -7.8225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.5510   -8.2572    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   15.4115   -8.2572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.1266   -7.8505    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   16.8418   -8.2852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.8418   -9.0938    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n   17.5709   -7.8786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   16.1266   -7.0372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   13.9953   -5.5789    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   12.5603   -6.6118    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   11.8592   -6.9952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.8732   -7.8225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.1488   -8.2524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.1628   -9.0845    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   10.4289   -7.8505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.4289   -7.0185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.1347   -6.5885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.7045   -6.6118    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    9.7045   -8.2618    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  4  3  2  0  0  0  0\n  5  4  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  7  1  0  0  0  0\n  8  3  1  0  0  0  0\n  7  8  2  0  0  0  0\n  9  8  1  0  0  0  0\n 10  6  1  0  0  0  0\n 11 10  1  0  0  0  0\n 12 11  1  0  0  0  0\n 13 12  1  0  0  0  0\n 14 12  2  0  0  0  0\n 11 15  1  1  0  0  0\n 16  4  1  0  0  0  0\n 17  3  1  0  0  0  0\n 18 17  1  0  0  0  0\n 19 18  1  0  0  0  0\n 20 19  2  0  0  0  0\n 21 20  1  0  0  0  0\n 20 22  1  0  0  0  0\n 22 23  2  0  0  0  0\n 23 24  1  0  0  0  0\n 24 18  2  0  0  0  0\n 25 23  1  0  0  0  0\n 26 22  1  0  0  0  0\nM  CHG  2   2   1  13  -1\nM  STY  1   1 MOD\nM  SCN  1   1 HT \nM  SAL   1  1   1\nM  SDI   1  4   13.8277  -10.2009   13.8277   -9.3609\nM  SDI   1  4   14.6677   -9.3609   14.6677  -10.2009\nM  END\n","EPA CompTox":["7054-08-2"],"name":"0H00N2AHSP","NCI_THESAURUS":["C65373"],"ChEMBL":["CHEMBL559"],"PreferredName":["DEXTROTHYROXINE SODIUM"],"id":"0H00N2AHSP","RXCUI":["40070"],"UNII":["0H00N2AHSP"]},{"Synonyms":["DEXTROTHYROXINE [VANDF]","D-THYROXINE [MI]","D-THYROXINE","DEXTROTHYROXINE [WHO-DD]","D-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-","DEXTROTHYROXINE"],"EVMPD":["SUB01651MIG"],"LIVERTOX":["294"],"ActiveMoieties":["4W9K63FION"],"ECHA (EC/EINECS)":["200-102-7"],"WHO-ATC":["C10AX01"],"MESH":["D003918"],"SMILES":"N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","IUPHAR":["6951"],"MERCK INDEX":["M10840"],"CAS":["51-49-0"],"DRUG BANK":["DB00509"],"References":["WEBSITE","DEXTROTHYROXINE [VANDF]","D-THYROXINE [MI]","DEXTROTHYROXINE [WHO-DD]","SRS import [4W9K63FION]","SRS CODE IMPORT","NDF-RT","MERCK","WHO-DD","USP DICTIONARY 2010","USP Dictionary 2010"],"MOLFILE":"4W9K63FION\n  Marvin  11101716422D          \n\n 24 25  0  0  1  0            999 V2000\n    7.1607   -6.2264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8607   -5.8139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5699   -6.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5699   -7.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8793   -7.4317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1607   -7.0284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4191   -7.4595    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2885   -7.4595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.0022   -7.0562    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   10.7208   -7.4919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.7208   -8.2985    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   11.4485   -7.0841    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   10.0022   -6.2403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8607   -4.7802    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4283   -5.8139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7284   -6.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7284   -7.0284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0146   -7.4548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0146   -8.2892    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2960   -7.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2960   -6.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0007   -5.7908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5683   -5.8139    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5683   -7.4641    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  2  1  0  0  0  0\n  3  4  2  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7  6  1  0  0  0  0\n  8  4  1  0  0  0  0\n  9  8  1  0  0  0  0\n 10  9  1  0  0  0  0\n 11 10  2  0  0  0  0\n 12 10  1  0  0  0  0\n  9 13  1  1  0  0  0\n 14  2  1  0  0  0  0\n 15  1  1  0  0  0  0\n 16 15  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  2  0  0  0  0\n 19 18  1  0  0  0  0\n 18 20  1  0  0  0  0\n 20 21  2  0  0  0  0\n 21 22  1  0  0  0  0\n 22 16  2  0  0  0  0\n 23 21  1  0  0  0  0\n 24 20  1  0  0  0  0\nM  END\n","EPA CompTox":["51-49-0"],"name":"4W9K63FION","NCI_THESAURUS":["C61719"],"ChEMBL":["CHEMBL559"],"PreferredName":["DEXTROTHYROXINE"],"id":"4W9K63FION","RXCUI":["3292"],"UNII":["4W9K63FION"],"WHO-VATC":["QC10AX01"]},{"Synonyms":["L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, HYDROCHLORIDE","RATHYRONINE HYDROCHLORIDE, (S)-","LIOTHYRONINE HYDROCHLORIDE [MI]","THYBON","LYOTHYRONIN","L-TRIIODOTHYRONINE HYDROCHLORIDE","L-3,5,3'-TRIIODOTHYRONINE HYDROCHLORIDE","3,5,3'-TRIIODOTHYRONINE HYDROCHLORIDE","3,5,3'-TRIIODO-L-THYRONINE HYDROCHLORIDE","ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, HYDROCHLORIDE, L-","LIOTHYRONINE HYDROCHLORIDE [WHO-DD]","LIOTHYRONINE HYDROCHLORIDE"],"EVMPD":["SUB02930MIG"],"ECHA (EC/EINECS)":["228-120-0"],"SMILES":"Cl.N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O","MERCK INDEX":["M6835"],"CAS":["6138-47-2"],"References":["WEBSITE","LIOTHYRONINE HYDROCHLORIDE [MI]","LIOTHYRONINE HYDROCHLORIDE [WHO-DD]","CHEMID  2012","SRS import [T66DHO0SET]","SRS CODE IMPORT","MERCK","STN","WHO-DD","NCI CADD 2012;WHO-DD"],"MOLFILE":"T66DHO0SET\n  Marvin  11101716422D          \n\n 24 24  0  0  1  0            999 V2000\n    2.4887   -6.0436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.7824   -6.4556    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.1949   -6.4298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.4887   -5.2123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.0616   -6.0436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.9010   -6.0031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.1949   -7.2574    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    3.1949   -4.8151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.8083   -4.7857    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    1.0616   -5.2123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.3554   -6.4556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.9010   -5.2123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.3958   -4.8151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.3508   -6.0436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.6182   -4.7857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.3508   -5.2123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.3958   -4.0390    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    5.3429   -5.1903    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   -1.0569   -4.8151    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    6.0490   -4.7637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.3539   -6.0178    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    6.7773   -5.1645    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    6.0343   -3.9324    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    8.6264   -5.5998    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  1  3  2  0  0  0  0\n  1  4  1  0  0  0  0\n  2  5  1  0  0  0  0\n  3  6  1  0  0  0  0\n  3  7  1  0  0  0  0\n  4  8  2  0  0  0  0\n  4  9  1  0  0  0  0\n  5 10  1  0  0  0  0\n  5 11  2  0  0  0  0\n  6 12  2  0  0  0  0\n 10 13  2  0  0  0  0\n 11 14  1  0  0  0  0\n 12 15  1  0  0  0  0\n 13 16  1  0  0  0  0\n 13 17  1  0  0  0  0\n 15 18  1  0  0  0  0\n 16 19  1  0  0  0  0\n 18 20  1  0  0  0  0\n 18 21  1  1  0  0  0\n 20 22  1  0  0  0  0\n 20 23  2  0  0  0  0\n  8 12  1  0  0  0  0\n 14 16  2  0  0  0  0\nM  END\n","EPA CompTox":["6138-47-2"],"name":"T66DHO0SET","PreferredName":["LIOTHYRONINE HYDROCHLORIDE"],"id":"T66DHO0SET","UNII":["T66DHO0SET"]},{"Synonyms":["THYROXINE (131I)","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, LABELED WITH IODINE-131","THYROXINE I 131 [USAN]","THYROXINE I 131","THYROXINE I-131","THYROXINE, I-131"],"ActiveMoieties":["66847MKV84"],"SMILES":"N[C@@H](CC1=CC([131I])=C(OC2=CC([131I])=C(O)C([131I])=C2)C([131I])=C1)C(O)=O","CAS":["7019-69-4"],"References":["WEBSITE","THYROXINE I 131 [USAN]","SRS import [66847MKV84]","SRS CODE IMPORT","CHEMBL","STN","USP DICTIONARY 2011","USP Dictionary 2011","FDA_SRS"],"EPA CompTox":["7019-69-4"],"MOLFILE":"66847MKV84\n  Marvin  11101716422D          \n\n 24 25  0  0  1  0            999 V2000\n    5.6479   -4.2134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.9335   -4.6260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2190   -4.2134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2190   -3.3884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5045   -2.9760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5045   -2.1510    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    2.7901   -3.3884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.0756   -2.9760    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    2.7901   -4.2134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.0756   -4.6260    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5045   -4.6260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.6479   -3.3884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.9335   -2.9760    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    6.3624   -2.9760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.0769   -3.3884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.7914   -2.9760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5059   -3.3884    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    9.2204   -2.9760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5059   -4.2134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.7914   -4.6260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2204   -4.6260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    7.0769   -4.2134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.3624   -4.6260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.3624   -5.4510    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  1  0  0  0  0\n  3  2  1  0  0  0  0\n  4  3  2  0  0  0  0\n  5  4  1  0  0  0  0\n  6  5  1  0  0  0  0\n  7  5  2  0  0  0  0\n  8  7  1  0  0  0  0\n  9  7  1  0  0  0  0\n 10  9  1  0  0  0  0\n  9 11  2  0  0  0  0\n 11  3  1  0  0  0  0\n 12  1  1  0  0  0  0\n 13 12  1  0  0  0  0\n 14 12  2  0  0  0  0\n 15 14  1  0  0  0  0\n 15 16  1  0  0  0  0\n 17 16  1  0  0  0  0\n 17 18  1  6  0  0  0\n 19 17  1  0  0  0  0\n 20 19  2  0  0  0  0\n 21 19  1  0  0  0  0\n 22 15  2  0  0  0  0\n 22 23  1  0  0  0  0\n 23  1  2  0  0  0  0\n 24 23  1  0  0  0  0\nM  ISO  4   6 131  10 131  13 131  24 131\nM  END\n","name":"66847MKV84","ChEMBL":["CHEMBL42115"],"id":"66847MKV84","PreferredName":["THYROXINE I-131"],"UNII":["66847MKV84"]},{"Synonyms":["DL-THYROXINE [MI]","(+/-)-3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE","O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-DL-TYROSINE","DL-THYROXINE","THYROXINE, DL-"],"ECHA (EC/EINECS)":["206-088-9"],"SMILES":"NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","MERCK INDEX":["M10840"],"CAS":["300-30-1"],"References":["WEBSITE","DL-THYROXINE [MI]","SRS import [QR0BV3BRIA]","SRS CODE IMPORT","FDA_SRS","MERCK","Merck"],"MOLFILE":"QR0BV3BRIA\n  Marvin  11101716442D          \n\n 24 25  0  0  0  0            999 V2000\n    7.1607   -6.2264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8607   -5.8139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5699   -6.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5699   -7.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8793   -7.4317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1607   -7.0284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4191   -7.4595    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2885   -7.4595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.0022   -7.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.7208   -7.4919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.7208   -8.2985    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   11.4485   -7.0841    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   10.0022   -6.2403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8607   -4.7802    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4283   -5.8139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7284   -6.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7284   -7.0284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0146   -7.4548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0146   -8.2892    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2960   -7.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2960   -6.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0007   -5.7908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5683   -5.8139    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5683   -7.4641    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  2  1  0  0  0  0\n  3  4  2  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7  6  1  0  0  0  0\n  8  4  1  0  0  0  0\n  9  8  1  0  0  0  0\n 10  9  1  0  0  0  0\n 11 10  2  0  0  0  0\n 12 10  1  0  0  0  0\n  9 13  1  0  0  0  0\n 14  2  1  0  0  0  0\n 15  1  1  0  0  0  0\n 16 15  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  2  0  0  0  0\n 19 18  1  0  0  0  0\n 18 20  1  0  0  0  0\n 20 21  2  0  0  0  0\n 21 22  1  0  0  0  0\n 22 16  2  0  0  0  0\n 23 21  1  0  0  0  0\n 24 20  1  0  0  0  0\nM  END\n","EPA CompTox":["300-30-1"],"name":"QR0BV3BRIA","NCI_THESAURUS":["C90975"],"PreferredName":["THYROXINE, DL-"],"id":"QR0BV3BRIA","UNII":["QR0BV3BRIA"]},{"Synonyms":["LIOTHYRONINE SODIUM [JAN]","NSC-80774","3,3',5-TRIIODO-L-THYRONINE SODIUM SALT","TRIIODOTHYRONINE SODIUM SALT","T3 SODIUM SALT","L-TRIIODOTHYRONINE SODIUM SALT","IBIOTHYRON","BASOPROCIN","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, SODIUM SALT (1:1)","ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, MONOSODIUM SALT, L-","RATHYRONINE SODIUM, (S)-","LIOTHYRONINE SODIUM [VANDF]","LIOTHYRONINE SODIUM [WHO-DD]","TERTROXIN","CYNOMEL","CYTOBIN","LIOTHYRONINE SODIUM SALT [MI]","LIOTHYRONINE SODIUM [GREEN BOOK]","LIOTHYRONINE SODIUM [MART.]","LIOTHYRONINE SODIUM [ORANGE BOOK]","LIOTHYRONINE SODIUM [USP]","LIOTHYRONINE SODIUM [EP]","TRIOSTAT","CYTOMEL","MONOSODIUM L-3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT","LIOTHYRONINE SODIUM"],"EVMPD":["SUB02931MIG"],"ActiveMoieties":["06LU7C9H1V"],"ECHA (EC/EINECS)":["200-223-5"],"WHO-ATC":["H03AA02"],"SMILES":"[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C([O-])=O","MERCK INDEX":["M6835"],"CAS":["55-06-1"],"References":["WEBSITE","JAN","LIOTHYRONINE SODIUM [VANDF]","LIOTHYRONINE SODIUM [WHO-DD]","LIOTHYRONINE SODIUM [GREEN BOOK]","LIOTHYRONINE SODIUM [MART.]","LIOTHYRONINE SODIUM [ORANGE BOOK]","LIOTHYRONINE SODIUM [USP]","LIOTHYRONINE SODIUM [EP]","USP Dictionary 2010","SRS import [GCA9VV7D2N]","SRS CODE IMPORT","CHEMID","TOX 21","STN","NDF-RT","WHO-DD","MERCK","FDA SRS 2011","MARTINDALE 2011","ORANGE BOOK 2011","USP 33","EP 7.2","ORANGE BOOK","USP DICTIONARY 2010","USP DICTIONARY 2008","USP Dictionary 2008"],"MOLFILE":"GCA9VV7D2N\n  Marvin  11101716442D          \n\n 24 24  0  0  1  0            999 V2000\n    3.5961   -6.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8795   -7.2335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5961   -5.9962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.7450   -6.8288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2999   -7.2464    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    2.1835   -5.9962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4421   -6.8391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7332   -7.2464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.7579   -5.9884    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    2.1680   -6.8159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.9027   -5.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0140   -6.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.4643   -5.5837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4421   -6.0039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.4539   -7.2335    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n    0.0335   -7.2387    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7332   -5.5991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8795   -8.0507    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2999   -5.5991    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1562   -7.2464    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0335   -5.5837    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0140   -5.9962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1562   -5.6095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3637   -8.1538    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  1  1  0  0  0  0\n  4  9  1  0  0  0  0\n  5  1  1  0  0  0  0\n  6 11  1  0  0  0  0\n  7  8  2  0  0  0  0\n  8 12  1  0  0  0  0\n  9 13  1  0  0  0  0\n 10  2  1  0  0  0  0\n 11  3  2  0  0  0  0\n 12  5  1  0  0  0  0\n 13  6  1  0  0  0  0\n 14 17  2  0  0  0  0\n 15  4  1  0  0  0  0\n 16  4  2  0  0  0  0\n 17 22  1  0  0  0  0\n 18  2  1  0  0  0  0\n 19  3  1  0  0  0  0\n 20  7  1  0  0  0  0\n  9 21  1  1  0  0  0\n 22 12  2  0  0  0  0\n 23 14  1  0  0  0  0\n 10  6  2  0  0  0  0\n 14  7  1  0  0  0  0\nM  CHG  2  15  -1  24   1\nM  END\n","EPA CompTox":["55-06-1"],"name":"GCA9VV7D2N","NCI_THESAURUS":["C2581"],"ChEMBL":["CHEMBL1544"],"PreferredName":["LIOTHYRONINE SODIUM"],"id":"GCA9VV7D2N","RXCUI":["142448"],"UNII":["GCA9VV7D2N"],"WHO-VATC":["QH03AA02"]},{"Synonyms":["LEVOTHYROXINE SODIUM HYDRATE [JAN]","TIROSINT-SOL","THYRO-TABS","SOLOXINE","OROXINE","LEVOTHYROX","LEVAXIN","EUTHYROX","EFEROX","LEVOTHYROXINE SODIUM HYDRATE [MI]","LEVOTHYROXINE SODIUM PENTAHYDRATE","SODIUM LEVOTHYROXINE PENTAHYDRATE","3',3,5',5-TETRAIODO-L-THYRONINE SODIUM SALT PENTAHYDRATE","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT, PENTAHYDRATE","ALANINE, 3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)-, MONOSODIUM SALT, PENTAHYDRATE, L-","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, SODIUM SALT, HYDRATE (1:1:5)","LEVOTHYROXINE SODIUM [VANDF]","ELTROXIN","LEVOTHYROXINE SODIUM [ORANGE BOOK]","LEVOTHYROXINE SODIUM [EP]","TIROSINT","NOVOTHYROX","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT, HYDRATE","UNITHROID","SYNTHROID","LEVOXYL","LEVOTHROID","LEVO-T","MONOSODIUM L-THYROXINE HYDRATE","SODIUM (2S)-2-AMINO-3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)PROPANOATE HYDRATE","LEVOTHYROXINE SODIUM"],"EVMPD":["SUB180911"],"ActiveMoieties":["Q51BO43MG4"],"WHO-ATC":["H03AA01"],"SMILES":"O.O.O.O.O.[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O","CAS":["6106-07-6"],"References":["JAN","LEVOTHYROXINE SODIUM [VANDF]","LEVOTHYROXINE SODIUM [ORANGE BOOK]","LEVOTHYROXINE SODIUM [EP]","SRS import [9J765S329G]","USP 36 LEVOTHYROXINE SODIUM MONOGRAPH","EP 7.8 LEVOTHYROXINE SODIUM MONOGRAPH","SRS CODE IMPORT","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206977s000lbl.pdf","MERCK","FDA_SRS","STN","NDF-RT","http://www.medsafe.govt.nz/profs/datasheet/e/Eltroxin(new)tab.pdf","ORANGE BOOK 2011","EP 7.2","ORANGE BOOK","USP DICTIONARY 2010","USP Dictionary 2010"],"MOLFILE":"9J765S329G\n  Marvin  11101716472D          \n\n 30 25  0  0  1  0            999 V2000\n   19.9216   -9.8907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   11.9337   -9.0359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.6344   -8.6248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.3398   -9.0079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.3398   -9.8627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.6484  -10.2411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.9337   -9.8347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.1957  -10.2691    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   14.0545  -10.2691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.7692   -9.8627    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   15.4839  -10.2971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.4839  -11.1053    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   16.2127   -9.8907    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n   14.7692   -9.0499    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   12.6344   -7.5926    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   11.2050   -8.6248    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   10.5043   -9.0079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.5043   -9.8347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.7943  -10.2645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.7943  -11.0959    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    9.0749   -9.8627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.0749   -9.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.7803   -8.6016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.3509   -8.6248    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    8.3509  -10.2737    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   17.6794   -9.8907    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n   19.9216   -9.8907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   19.9216   -9.8907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   19.9216   -9.8907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   19.9216   -9.8907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  3  2  2  0  0  0  0\n  4  3  1  0  0  0  0\n  4  5  2  0  0  0  0\n  5  6  1  0  0  0  0\n  6  7  2  0  0  0  0\n  7  2  1  0  0  0  0\n  8  7  1  0  0  0  0\n  9  5  1  0  0  0  0\n 10  9  1  0  0  0  0\n 11 10  1  0  0  0  0\n 12 11  2  0  0  0  0\n 13 11  1  0  0  0  0\n 10 14  1  6  0  0  0\n 15  3  1  0  0  0  0\n 16  2  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  1  0  0  0  0\n 19 18  2  0  0  0  0\n 20 19  1  0  0  0  0\n 19 21  1  0  0  0  0\n 21 22  2  0  0  0  0\n 22 23  1  0  0  0  0\n 23 17  2  0  0  0  0\n 24 22  1  0  0  0  0\n 25 21  1  0  0  0  0\nM  CHG  2  13  -1  26   1\nM  STY  1   1 MUL\nM  SCN  1   1 HT \nM  SAL   1  5   1  27  28  29  30\nM  SPA   1  1   1\nM  SDI   1  4   19.5016  -10.3107   19.5016   -9.4707\nM  SDI   1  4   20.3416   -9.4707   20.3416  -10.3107\nM  SMT   1 5\nM  END\n","name":"9J765S329G","NCI_THESAURUS":["C888"],"ChEMBL":["CHEMBL1624"],"PreferredName":["LEVOTHYROXINE SODIUM"],"id":"9J765S329G","RXCUI":["40144"],"UNII":["9J765S329G"],"WHO-VATC":["QH03AA01"]},{"Synonyms":["TRIONINE","TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, HYDROCHLORIDE","DL-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, HYDROCHLORIDE","TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, HYDROCHLORIDE (1:1)","RATHYRONINE HYDROCHLORIDE"],"CAS":["65466-14-0"],"References":["SRS import [A247F3O99B]","SRS CODE IMPORT","STN"],"name":"A247F3O99B","MOLFILE":"A247F3O99B\n  Marvin  11101716482D          \n\n 24 24  0  0  0  0            999 V2000\n    7.7891   -3.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.0940   -3.2485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.3667   -3.6582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.3667   -4.4638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.0709   -4.8825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.7891   -4.4776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5301   -4.9010    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    5.6671   -4.9010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.9629   -4.4821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2540   -4.8825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2540   -5.7065    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5452   -4.4776    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    4.9629   -3.6444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    7.0940   -2.4061    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5117   -3.2485    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2159   -3.6582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2159   -4.4867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.9202   -4.8687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.9202   -5.6834    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   10.6382   -4.4545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.6382   -3.6259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.9157   -3.2210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.3563   -4.8549    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    8.2852   -7.0424    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  2  1  0  0  0  0\n  3  4  2  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7  6  1  0  0  0  0\n  8  4  1  0  0  0  0\n  9  8  1  0  0  0  0\n 10  9  1  0  0  0  0\n 11 10  2  0  0  0  0\n 12 10  1  0  0  0  0\n  9 13  1  0  0  0  0\n 14  2  1  0  0  0  0\n 15  1  1  0  0  0  0\n 16 15  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  2  0  0  0  0\n 19 18  1  0  0  0  0\n 20 18  1  0  0  0  0\n 20 21  2  0  0  0  0\n 21 22  1  0  0  0  0\n 22 16  2  0  0  0  0\n 23 20  1  0  0  0  0\nM  END\n","SMILES":"Cl.NC(CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O","id":"A247F3O99B","PreferredName":["RATHYRONINE HYDROCHLORIDE"],"UNII":["A247F3O99B"]},{"Synonyms":["LEVOTHYROXINUM NATRICUM MONOHYDRATE [WHO-IP LATIN]","LEVOTHYROXINE SODIUM MONOHYDRATE [WHO-IP]","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT, MONOHYDRATE","LEVOTHYROXINE SODIUM MONOHYDRATE"],"ActiveMoieties":["Q51BO43MG4"],"SMILES":"O.[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O","WHO INTERNATIONAL PHARMACOPEIA":["LEVOTHYROXINE SODIUM MONOHYDRATE"],"CAS":["31178-59-3"],"References":["LEVOTHYROXINE SODIUM MONOHYDRATE [WHO-IP]","SRS import [B82379R9W0]","SRS CODE IMPORT","WHO-IP","STN"],"MOLFILE":"B82379R9W0\n  Marvin  11101716502D          \n\n 26 25  0  0  1  0            999 V2000\n   19.4140  -10.0012    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   11.4261   -9.1463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.1268   -8.7352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.8322   -9.1183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.8322   -9.9731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.1408  -10.3515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.4261   -9.9451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.6881  -10.3795    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   13.5469  -10.3795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.2616   -9.9731    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   14.9763  -10.4076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.9763  -11.2158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   15.7050  -10.0012    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n   14.2616   -9.1603    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   12.1268   -7.7030    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   10.6974   -8.7352    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    9.9967   -9.1183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.9967   -9.9451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2867  -10.3749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2867  -11.2064    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5673   -9.9731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5673   -9.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2727   -8.7120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8433   -8.7352    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8433  -10.3841    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   17.1718  -10.0012    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n  3  2  2  0  0  0  0\n  4  3  1  0  0  0  0\n  4  5  2  0  0  0  0\n  5  6  1  0  0  0  0\n  6  7  2  0  0  0  0\n  7  2  1  0  0  0  0\n  8  7  1  0  0  0  0\n  9  5  1  0  0  0  0\n 10  9  1  0  0  0  0\n 11 10  1  0  0  0  0\n 12 11  2  0  0  0  0\n 13 11  1  0  0  0  0\n 10 14  1  6  0  0  0\n 15  3  1  0  0  0  0\n 16  2  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  1  0  0  0  0\n 19 18  2  0  0  0  0\n 20 19  1  0  0  0  0\n 19 21  1  0  0  0  0\n 21 22  2  0  0  0  0\n 22 23  1  0  0  0  0\n 23 17  2  0  0  0  0\n 24 22  1  0  0  0  0\n 25 21  1  0  0  0  0\nM  CHG  2  13  -1  26   1\nM  END\n","name":"B82379R9W0","id":"B82379R9W0","PreferredName":["LEVOTHYROXINE SODIUM MONOHYDRATE"],"UNII":["B82379R9W0"]},{"Synonyms":["THYROXINE I 123","L-TYROSINE, O-(4-HYDROXY-3,5-DI(IODO-123I)PHENYL)-3,5-DI(IODO-123I)-","THYROXINE I-123"],"CAS":["60345-91-7"],"References":["SRS import [916A14ZM1H]","SRS CODE IMPORT","STN","FDA_SRS"],"name":"916A14ZM1H","MOLFILE":"916A14ZM1H\n  Marvin  11101716502D          \n\n 24 25  0  0  1  0            999 V2000\n    9.7862   -6.8387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.5006   -7.2512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.5006   -8.0762    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   11.2151   -6.8387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.2151   -6.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.9296   -5.6012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.6441   -6.0137    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   13.3586   -5.6012    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   12.6441   -6.8387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.3586   -7.2512    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   11.9296   -7.2512    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   10.5006   -5.6012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.7862   -6.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.0717   -5.6012    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    9.0717   -7.2512    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    8.3572   -6.8387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.6428   -7.2512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.9283   -6.8387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.2139   -7.2512    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    6.9283   -6.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.2139   -5.6012    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    7.6428   -5.6012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.6428   -4.7762    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    8.3572   -6.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  2  1  0  0  0  0\n  4  2  1  0  0  0  0\n  4  5  2  0  0  0  0\n  5  6  1  0  0  0  0\n  7  6  1  0  0  0  0\n  7  8  1  6  0  0  0\n  9  7  1  0  0  0  0\n 10  9  1  0  0  0  0\n 11  9  2  0  0  0  0\n  5 12  1  0  0  0  0\n 12 13  2  0  0  0  0\n 13  1  1  0  0  0  0\n 14 13  1  0  0  0  0\n 15  1  1  0  0  0  0\n 16 15  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  2  0  0  0  0\n 19 18  1  0  0  0  0\n 18 20  1  0  0  0  0\n 21 20  1  0  0  0  0\n 20 22  2  0  0  0  0\n 23 22  1  0  0  0  0\n 22 24  1  0  0  0  0\n 24 16  2  0  0  0  0\nM  ISO  4   3 123  14 123  19 123  23 123\nM  END\n","SMILES":"N[C@@H](CC1=CC([123I])=C(OC2=CC([123I])=C(O)C([123I])=C2)C([123I])=C1)C(O)=O","id":"916A14ZM1H","PreferredName":["THYROXINE I-123"],"UNII":["916A14ZM1H"]},{"Synonyms":["THYROXINE I 125 [WHO-DD]","THYROXINE I 125 [USAN]","THYROXINE I 125","THYROXINE I-125","THYROXINE-125I","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, LABELED WITH IODINE-125","THYROXINE, I-125"],"EVMPD":["SUB15565MIG"],"ActiveMoieties":["7U4LEE5872"],"SMILES":"N[C@@H](CC1=CC([125I])=C(OC2=CC([125I])=C(O)C([125I])=C2)C([125I])=C1)C(O)=O","CAS":["24486-40-6"],"References":["THYROXINE I 125 [WHO-DD]","THYROXINE I 125 [USAN]","STN","SRS import [7U4LEE5872]","SRS CODE IMPORT","WHO-DD","USP DICTIONARY 2011","USP Dictionary 2011","stn","FDA_SRS"],"MOLFILE":"7U4LEE5872\n  Marvin  11101716512D          \n\n 24 25  0  0  1  0            999 V2000\n    5.1854   -4.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.8998   -4.4327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.8998   -5.2577    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    6.6143   -4.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.6143   -3.1952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.3288   -2.7827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.0432   -3.1952    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    8.7577   -2.7827    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    8.0432   -4.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.7577   -4.4327    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    7.3288   -4.4327    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    5.8998   -2.7827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.1854   -3.1952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.4709   -2.7827    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    4.4709   -4.4327    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.7564   -4.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.0420   -4.4327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.3275   -4.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.6130   -4.4327    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    2.3275   -3.1952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.6130   -2.7827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.0420   -2.7827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.0420   -1.9577    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    3.7564   -3.1952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  2  1  0  0  0  0\n  4  2  1  0  0  0  0\n  4  5  2  0  0  0  0\n  5  6  1  0  0  0  0\n  7  6  1  0  0  0  0\n  7  8  1  6  0  0  0\n  9  7  1  0  0  0  0\n 10  9  1  0  0  0  0\n 11  9  2  0  0  0  0\n  5 12  1  0  0  0  0\n 12 13  2  0  0  0  0\n 13  1  1  0  0  0  0\n 14 13  1  0  0  0  0\n 15  1  1  0  0  0  0\n 16 15  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  2  0  0  0  0\n 19 18  1  0  0  0  0\n 18 20  1  0  0  0  0\n 21 20  1  0  0  0  0\n 20 22  2  0  0  0  0\n 23 22  1  0  0  0  0\n 22 24  1  0  0  0  0\n 24 16  2  0  0  0  0\nM  ISO  4   3 125  14 125  19 125  23 125\nM  END\n","name":"7U4LEE5872","ChEMBL":["CHEMBL42115"],"id":"7U4LEE5872","PreferredName":["THYROXINE I-125"],"UNII":["7U4LEE5872"]},{"Synonyms":["RATHYRONINE, (R)-","NSC-46046","DEXTROTHYRONINE","3,3',5-TRIIODO-D-THYRONINE","(+)-TRIIODOTHYRONINE","ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, D-","D-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-","DETROTHYRONINE [MART.]","DETROTHYRONINE [INN]","DT-3","D-3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-ALANINE","DETROTHYRONINE"],"EVMPD":["SUB07014MIG"],"ActiveMoieties":["46XII7C16X"],"ECHA (EC/EINECS)":["227-203-9"],"INN":["1008"],"SMILES":"N[C@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O","CAS":["5714-08-9"],"References":["DETROTHYRONINE [MART.]","DETROTHYRONINE [INN]","SRS import [46XII7C16X]","SRS CODE IMPORT","STN","MARTINDALE 2011","INN 2010","USP DICTIONARY 2010","inn"],"MOLFILE":"46XII7C16X\n  Marvin  11101716542D          \n\n 23 24  0  0  1  0            999 V2000\n    7.7957   -2.8573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1002   -2.4565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.3723   -2.8666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.3723   -3.6729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.0772   -4.0920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.7957   -3.6867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5375   -4.1105    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    5.6720   -4.1105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.9672   -3.6912    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    4.2577   -4.0920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2577   -4.9167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5483   -3.6867    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    4.9672   -2.8528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1002   -1.6135    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5190   -2.4565    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2194   -2.8666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2194   -3.6959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.9242   -4.0782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.9242   -4.8937    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   10.6474   -3.6590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.6474   -2.8343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.9241   -2.4290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.3661   -4.0644    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  2  1  0  0  0  0\n  3  4  2  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7  6  1  0  0  0  0\n  8  4  1  0  0  0  0\n  9  8  1  0  0  0  0\n 10  9  1  0  0  0  0\n 11 10  2  0  0  0  0\n 12 10  1  0  0  0  0\n  9 13  1  6  0  0  0\n 14  2  1  0  0  0  0\n 15  1  1  0  0  0  0\n 16 15  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  2  0  0  0  0\n 19 18  1  0  0  0  0\n 20 18  1  0  0  0  0\n 20 21  2  0  0  0  0\n 21 22  1  0  0  0  0\n 22 16  2  0  0  0  0\n 23 20  1  0  0  0  0\nM  END\n","name":"46XII7C16X","ChEMBL":["CHEMBL557"],"PreferredName":["DETROTHYRONINE"],"id":"46XII7C16X","UNII":["46XII7C16X"]},{"Synonyms":["DL-TRIIODOTHYRONINE","3,3',5-TRIIODO-DL-THYRONINE","DL-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-","ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, DL-","TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-","LIOTHYRONINE, DL-","RATHYRONINE [INN]","DL-3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE","RATHYRONINE"],"EVMPD":["SUB10262MIG"],"ActiveMoieties":["O48UO55HR0"],"ECHA (EC/EINECS)":["221-522-7"],"INN":["3213"],"SMILES":"NC(CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O","CAS":["3130-96-9"],"References":["RATHYRONINE [INN]","SRS import [O48UO55HR0]","SRS CODE IMPORT","STN","FDA_SRS","INN 2010","USP DICTIONARY 2009"],"MOLFILE":"O48UO55HR0\n  Marvin  11101716572D          \n\n 23 24  0  0  0  0            999 V2000\n   -1.1244   -2.1658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.8380   -1.7675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.1410   -2.9957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -4.6802   -3.4023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.4190   -1.7675    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.5641   -2.9833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.9916   -3.3857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.3029   -3.0040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -3.9707   -2.9998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.5559   -2.1742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.8588   -3.4023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.2863   -2.1742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -3.2654   -3.4189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.7135   -2.9708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -4.6926   -4.2280    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    1.6970   -2.1451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.8297   -0.9211    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.3983   -3.4189    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    1.0082   -4.2031    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -3.9789   -2.1617    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   -5.3897   -2.9957    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.9875   -1.7385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.4314   -3.3732    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  1  1  0  0  0  0\n  4  9  1  0  0  0  0\n  5  1  1  0  0  0  0\n  6 11  1  0  0  0  0\n  7  8  2  0  0  0  0\n  8 12  1  0  0  0  0\n  9 13  1  0  0  0  0\n 10  2  1  0  0  0  0\n 11  3  2  0  0  0  0\n 12  5  1  0  0  0  0\n 13  6  1  0  0  0  0\n 14 16  2  0  0  0  0\n 15  4  2  0  0  0  0\n 16 22  1  0  0  0  0\n 17  2  1  0  0  0  0\n 18  3  1  0  0  0  0\n 19  7  1  0  0  0  0\n  9 20  1  0  0  0  0\n 21  4  1  0  0  0  0\n 22 12  2  0  0  0  0\n 23 14  1  0  0  0  0\n 10  6  2  0  0  0  0\n 14  7  1  0  0  0  0\nM  END\n","name":"O48UO55HR0","NCI_THESAURUS":["C61710"],"ChEMBL":["CHEMBL789"],"PreferredName":["RATHYRONINE"],"id":"O48UO55HR0","UNII":["O48UO55HR0"]},{"Synonyms":["NSC-259940","LEVOTHYROXINUM NATRICUM ANHYDROUS [WHO-IP LATIN]","LEVOTHYROXINE SODIUM ANHYDROUS [WHO-IP]","THYROXINE SODIUM","THYROXINE SODIUM SALT [MI]","THYROXINE SODIUM SALT","LEVOTHYROXINE SODIUM [WHO-DD]","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT","LEVOTHYROXINE SODIUM [INN]","LEVOTHYROXINE SODIUM ANHYDROUS"],"EVMPD":["SUB08495MIG"],"ActiveMoieties":["Q51BO43MG4"],"ECHA (EC/EINECS)":["200-221-4"],"INN":["453"],"SMILES":"[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O","WHO INTERNATIONAL PHARMACOPEIA":["LEVOTHYROXINE SODIUM ANHYDROUS"],"MERCK INDEX":["M10840"],"CAS":["55-03-8"],"References":["LEVOTHYROXINE SODIUM ANHYDROUS [WHO-IP]","THYROXINE SODIUM SALT [MI]","INN 2010","SRS import [054I36CPMN]","SRS CODE IMPORT","CHEMID","WHO-IP","http://www.drugoffice.gov.hk/eps/productDetailActionNew.do?lang=en&section=consumer&id=105287","MERCK","WHO-DD","USP DICTIONARY 2011","INN","USP DICTIONARY 2010"],"MOLFILE":"054I36CPMN\n  Marvin  11101716582D          \n\n 25 25  0  0  1  0            999 V2000\n    1.9445   -2.6221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.9020   -3.4495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1822   -3.8514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.9020   -2.6174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.6596   -2.2108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.9585   -3.4214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5282   -2.5941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.5108   -3.8841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.2294   -2.2108    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5423   -3.4214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1962   -2.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.3654   -3.4495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.7957   -3.4495    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    2.6736   -3.8281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.3888   -2.5941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.0806   -3.8561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.5108   -4.6927    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    6.2400   -3.4775    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n   -1.6265   -2.2108    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1682   -4.6834    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    1.2200   -3.8561    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    2.6643   -1.1779    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.6265   -3.8607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    4.7957   -2.6362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    7.7076   -3.4775    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n  2  4  2  0  0  0  0\n  3 10  2  0  0  0  0\n  4 11  1  0  0  0  0\n  5  1  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7  9  1  0  0  0  0\n  8 13  1  0  0  0  0\n  9  1  1  0  0  0  0\n 10  7  1  0  0  0  0\n 11  7  2  0  0  0  0\n 12 14  1  0  0  0  0\n 13 16  1  0  0  0  0\n 14  6  2  0  0  0  0\n 15  5  1  0  0  0  0\n 16 12  1  0  0  0  0\n 17  8  2  0  0  0  0\n 18  8  1  0  0  0  0\n 19  4  1  0  0  0  0\n 20  3  1  0  0  0  0\n 21  6  1  0  0  0  0\n 22  5  1  0  0  0  0\n 23  2  1  0  0  0  0\n 13 24  1  6  0  0  0\n 15 12  2  0  0  0  0\n  3  2  1  0  0  0  0\nM  CHG  2  18  -1  25   1\nM  END\n","name":"054I36CPMN","PreferredName":["LEVOTHYROXINE SODIUM ANHYDROUS"],"id":"054I36CPMN","RXCUI":["1372638"],"UNII":["054I36CPMN"]},{"Synonyms":["D-THYROXINE SODIUM SALT [MI]","D-THYROXINE SODIUM SALT","SODIUM DEXTROTHYROXINE","ANHYDROUS DEXTROTHYROXINE SODIUM [MART.]","ANHYDROUS DEXTROTHYROXINE SODIUM","DEXTROTHYROXINE SODIUM [WHO-DD]","DEXTROTHYROXINE SODIUM [INN]","DEXTROTHYROXINE SODIUM ANHYDROUS"],"EVMPD":["SUB07055MIG"],"ActiveMoieties":["4W9K63FION"],"ECHA (EC/EINECS)":["205-301-2"],"INN":["1112"],"SMILES":"[Na+].N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O","MERCK INDEX":["M10840"],"CAS":["137-53-1"],"References":["D-THYROXINE SODIUM SALT [MI]","ANHYDROUS DEXTROTHYROXINE SODIUM [MART.]","SRS import [J60FX7V025]","SRS CODE IMPORT","MERCK","CFSAN","MARTINDALE","WHO-DD","INN 2010","USP DICTIONARY 2010"],"MOLFILE":"J60FX7V025\n  Marvin  11101716582D          \n\n 25 25  0  0  1  0            999 V2000\n    5.9780   -5.9594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.1315   -6.7867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.8514   -7.1887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.1315   -5.9547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.6932   -5.5481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.9921   -6.7587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.5618   -5.9314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.5444   -7.2214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.2629   -5.5481    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    4.5758   -6.7587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.8374   -5.5247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.3990   -6.7867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.8293   -6.7867    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    6.7072   -7.1653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.4223   -5.9314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.1141   -7.1934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.5444   -8.0300    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n   10.2735   -6.8148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    2.4071   -5.5481    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    3.8654   -8.0207    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    5.2536   -7.1934    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    6.6979   -4.5151    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    2.4071   -7.1980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    8.8293   -5.9734    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    5.3565   -8.7171    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n  2  4  2  0  0  0  0\n  3 10  2  0  0  0  0\n  4 11  1  0  0  0  0\n  5  1  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7  9  1  0  0  0  0\n  8 13  1  0  0  0  0\n  9  1  1  0  0  0  0\n 10  7  1  0  0  0  0\n 11  7  2  0  0  0  0\n 12 14  1  0  0  0  0\n 13 16  1  0  0  0  0\n 14  6  2  0  0  0  0\n 15  5  1  0  0  0  0\n 16 12  1  0  0  0  0\n 17  8  1  0  0  0  0\n 18  8  2  0  0  0  0\n 19  4  1  0  0  0  0\n 20  3  1  0  0  0  0\n 21  6  1  0  0  0  0\n 22  5  1  0  0  0  0\n 23  2  1  0  0  0  0\n 13 24  1  1  0  0  0\n 15 12  2  0  0  0  0\n  3  2  1  0  0  0  0\nM  CHG  2  17  -1  25   1\nM  END\n","name":"J60FX7V025","PreferredName":["DEXTROTHYROXINE SODIUM ANHYDROUS"],"id":"J60FX7V025","UNII":["J60FX7V025"]},{"Synonyms":["LIOTHYRONINE I 131 [USAN]","LIOTHYRONINE I 131","L-ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, LABELED WITH IODINE-131","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, LABELED WITH IODINE-131","LIOTHYRONINE I-131"],"SMILES":"N[C@@H](CC1=CC([131I])=C(OC2=CC=C(O)C([131I])=C2)C([131I])=C1)C(O)=O","CAS":["20196-64-9"],"References":["LIOTHYRONINE I 131 [USAN]","SRS import [86AZ0G22V2]","SRS CODE IMPORT","USP DICTIONARY 2013","USP DICTIONARY 2008"],"MOLFILE":"86AZ0G22V2\n  Marvin  11101716582D          \n\n 23 24  0  0  1  0            999 V2000\n    6.4566   -2.1370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7429   -1.7386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4400   -2.9669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.9005   -3.3736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5729   -3.3569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1620   -1.7386    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0168   -2.9545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8840   -2.9752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7512   -0.8921    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    7.6517   -3.7139    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0250   -2.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7222   -3.3736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.6101   -2.9710    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    8.5895   -4.1745    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8675   -2.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.3155   -3.3902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2949   -2.9420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8881   -4.1993    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2783   -2.1163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.6017   -2.1329    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    2.1909   -2.9669    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5687   -1.7096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.0127   -3.3445    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  1  1  0  0  0  0\n  4 13  1  0  0  0  0\n  5  8  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7 12  1  0  0  0  0\n  8 15  1  0  0  0  0\n  9  2  1  0  0  0  0\n 10  3  1  0  0  0  0\n 11  2  1  0  0  0  0\n 12  3  2  0  0  0  0\n 13 16  1  0  0  0  0\n 14  5  1  0  0  0  0\n 15  6  1  0  0  0  0\n 16  7  1  0  0  0  0\n 17 19  2  0  0  0  0\n 18  4  2  0  0  0  0\n 19 22  1  0  0  0  0\n 13 20  1  1  0  0  0\n 21  4  1  0  0  0  0\n 22 15  2  0  0  0  0\n 23 17  1  0  0  0  0\n 11  7  2  0  0  0  0\n 17  5  1  0  0  0  0\nM  ISO  3   9 131  10 131  14 131\nM  END\n","name":"86AZ0G22V2","NCI_THESAURUS":["C2396"],"ChEMBL":["CHEMBL1544"],"id":"86AZ0G22V2","PreferredName":["LIOTHYRONINE I-131"],"UNII":["86AZ0G22V2"]},{"Synonyms":["LIOTHYRONINE I 125 [USAN]","LIOTHYRONINE I 125","LIOTHYRONINE (125I)","L-ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, LABELED WITH IODINE-125","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, LABELED WITH IODINE-125","LIOTHYRONINE I-125"],"SMILES":"N[C@@H](CC1=CC([125I])=C(OC2=CC=C(O)C([125I])=C2)C([125I])=C1)C(O)=O","CAS":["24359-14-6"],"References":["LIOTHYRONINE I 125 [USAN]","SRS import [S1UAI9MKMG]","SRS CODE IMPORT","USP DICTIONARY 2013","chembl","USP DICTIONARY 2008"],"MOLFILE":"S1UAI9MKMG\n  Marvin  11101716592D          \n\n 23 24  0  0  1  0            999 V2000\n    6.4566   -2.1370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7429   -1.7386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4400   -2.9669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.9005   -3.3736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5729   -3.3569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1620   -1.7386    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0168   -2.9545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8840   -2.9752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7512   -0.8921    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    7.6517   -3.7139    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0250   -2.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7222   -3.3736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.6101   -2.9710    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    8.5895   -4.1745    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8675   -2.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.3155   -3.3902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2949   -2.9420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8881   -4.1993    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2783   -2.1163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.6017   -2.1329    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    2.1909   -2.9669    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    8.5687   -1.7096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.0127   -3.3445    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  3  1  1  0  0  0  0\n  4 13  1  0  0  0  0\n  5  8  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7 12  1  0  0  0  0\n  8 15  1  0  0  0  0\n  9  2  1  0  0  0  0\n 10  3  1  0  0  0  0\n 11  2  1  0  0  0  0\n 12  3  2  0  0  0  0\n 13 16  1  0  0  0  0\n 14  5  1  0  0  0  0\n 15  6  1  0  0  0  0\n 16  7  1  0  0  0  0\n 17 19  2  0  0  0  0\n 18  4  2  0  0  0  0\n 19 22  1  0  0  0  0\n 13 20  1  1  0  0  0\n 21  4  1  0  0  0  0\n 22 15  2  0  0  0  0\n 23 17  1  0  0  0  0\n 11  7  2  0  0  0  0\n 17  5  1  0  0  0  0\nM  ISO  3   9 125  10 125  14 125\nM  END\n","name":"S1UAI9MKMG","NCI_THESAURUS":["C80096"],"ChEMBL":["CHEMBL1544"],"id":"S1UAI9MKMG","PreferredName":["LIOTHYRONINE I-125"],"UNII":["S1UAI9MKMG"]},{"COMPOUND_QCD":["false"],"CompoundName":["THYROXINE I-131"],"CompoundSynonym":["L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, LABELED WITH IODINE-131","THYROXINE I 131","THYROXINE I-131","THYROXINE, I-131","THYROXINE, LABELED WITH IODINE-131","TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, LABELED WITH IODINE-131"],"CompoundSmiles":["N[C@@H](CC1=CC([131I])=C(OC2=CC([131I])=C(O)C([131I])=C2)C([131I])=C1)C(O)=O"],"SMILES":"N[C@@H](CC1=CC([131I])=C(OC2=CC([131I])=C(O)C([131I])=C2)C([131I])=C1)C(O)=O","Unii":["66847MKV84"],"ChemSpiderID":["2297479"],"Cas":["7525-17-9"],"Completed":["false"],"MOLFILE":"\n  Marvin  11101717010D          \n\n 24 25  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  1  0  0  0  0\n 12 14  2  3  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  2  3  0  0  0\n 10 18  1  0  0  0  0\n  8 19  1  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  2  3  0  0  0\n  4 21  1  0  0  0  0\n  2 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  ISO  4   7 131  13 131  17 131  20 131\nM  END\n","id":"THYROXINE I-131","Iupac":["(2S)-2-amino-3-[4-[4-hydroxy-3,5-bis(iodanyl)phenoxy]-3,5-bis(iodanyl)phenyl]propanoic acid"],"Cid":["3032526"]},{"COMPOUND_QCD":["false"],"CompoundName":["THYROXINE I-123"],"CompoundSynonym":["THYROXINE I-123","THYROXINE I 123","L-TYROSINE, O-(4-HYDROXY-3,5-DI(IODO-123I)PHENYL)-3,5-DI(IODO-123I)-"],"CompoundSmiles":["N[C@@H](CC1=CC([123I])=C(OC2=CC([123I])=C(O)C([123I])=C2)C([123I])=C1)C(O)=O"],"SMILES":"N[C@@H](CC1=CC([123I])=C(OC2=CC([123I])=C(O)C([123I])=C2)C([123I])=C1)C(O)=O","Unii":["916A14ZM1H"],"ChemSpiderID":["5614"],"Cas":["60345-91-7"],"Completed":["false"],"MOLFILE":"\n  Marvin  11101717070D          \n\n 24 25  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  1  0  0  0  0\n 12 14  2  3  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  2  3  0  0  0\n 10 18  1  0  0  0  0\n  8 19  1  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  2  3  0  0  0\n  4 21  1  0  0  0  0\n  2 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  ISO  4   7 123  13 123  17 123  20 123\nM  END\n","id":"THYROXINE I-123","Iupac":["(2S)-2-amino-3-[4-[4-hydroxy-3,5-bis(iodanyl)phenoxy]-3,5-bis(iodanyl)phenyl]propanoic acid"],"Cid":["91810528"]},{"COMPOUND_QCD":["false"],"CompoundName":["THYROXINE I-125"],"CompoundSynonym":["THYROXINE, I-125","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, LABELED WITH IODINE-125","THYROXINE I 125","THYROXINE I-125","THYROXINE-125I"],"CompoundSmiles":["N[C@@H](CC1=CC([125I])=C(OC2=CC([125I])=C(O)C([125I])=C2)C([125I])=C1)C(O)=O"],"SMILES":"N[C@@H](CC1=CC([125I])=C(OC2=CC([125I])=C(O)C([125I])=C2)C([125I])=C1)C(O)=O","Unii":["7U4LEE5872"],"ChemSpiderID":["30791816"],"Cas":["24359-16-8"],"Completed":["false"],"MOLFILE":"\n  Marvin  11101717090D          \n\n 24 25  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  1  0  0  0  0\n 12 14  2  3  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  2  3  0  0  0\n 10 18  1  0  0  0  0\n  8 19  1  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  2  3  0  0  0\n  4 21  1  0  0  0  0\n  2 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  ISO  4   7 125  13 125  17 125  20 125\nM  END\n","id":"THYROXINE I-125","Iupac":["(2S)-2-amino-3-[4-[4-hydroxy-3,5-bis(iodanyl)phenoxy]-3,5-bis(iodanyl)phenyl]propanoic acid"],"Cid":["23725048"]},{"COMPOUND_QCD":["false"],"CompoundName":["LIOTHYRONINE I-131"],"CompoundSynonym":["L-ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, LABELED WITH IODINE-131","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, LABELED WITH IODINE-131","LIOTHYRONINE I 131","LIOTHYRONINE I-131"],"CompoundSmiles":["N[C@@H](CC1=CC([131I])=C(OC2=CC=C(O)C([131I])=C2)C([131I])=C1)C(O)=O"],"SMILES":"N[C@@H](CC1=CC([131I])=C(OC2=CC=C(O)C([131I])=C2)C([131I])=C1)C(O)=O","Unii":["86AZ0G22V2"],"ChemSpiderID":["28528366"],"Cas":["20196-64-9"],"Completed":["false"],"MOLFILE":"\n  Marvin  11101717140D          \n\n 23 24  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  2  3  0  0  0\n 13 14  1  0  0  0  0\n 13 15  1  0  0  0  0\n 15 16  1  0  0  0  0\n 15 17  2  3  0  0  0\n 10 17  1  0  0  0  0\n  8 18  1  0  0  0  0\n 18 19  1  0  0  0  0\n 18 20  2  3  0  0  0\n  4 20  1  0  0  0  0\n  2 21  1  0  0  0  0\n 21 22  1  0  0  0  0\n 21 23  2  0  0  0  0\nM  ISO  3   7 131  16 131  19 131\nM  END\n","id":"LIOTHYRONINE I-131","Iupac":["(2S)-2-amino-3-[4-(4-hydroxy-3-iodanylphenoxy)-3,5-bis(iodanyl)phenyl]propanoic acid"],"Cid":["23724940"]},{"COMPOUND_QCD":["false"],"Unii":["S1UAI9MKMG"],"ChemSpiderID":["151066"],"CompoundName":["LIOTHYRONINE I-125"],"CompoundSynonym":["L-ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, LABELED WITH IODINE-125","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, LABELED WITH IODINE-125","LIOTHYRONINE I 125","LIOTHYRONINE I-125"],"Cas":["24359-14-6"],"CompoundSmiles":["N[C@@H](CC1=CC([125I])=C(OC2=CC=C(O)C([125I])=C2)C([125I])=C1)C(O)=O"],"Completed":["false"],"MOLFILE":"\n  Marvin  11101717150D          \n\n 23 24  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  2  3  0  0  0\n 13 14  1  0  0  0  0\n 13 15  1  0  0  0  0\n 15 16  1  0  0  0  0\n 15 17  2  3  0  0  0\n 10 17  1  0  0  0  0\n  8 18  1  0  0  0  0\n 18 19  1  0  0  0  0\n 18 20  2  3  0  0  0\n  4 20  1  0  0  0  0\n  2 21  1  0  0  0  0\n 21 22  1  0  0  0  0\n 21 23  2  0  0  0  0\nM  ISO  3   7 125  16 125  19 125\nM  END\n","SMILES":"N[C@@H](CC1=CC([125I])=C(OC2=CC=C(O)C([125I])=C2)C([125I])=C1)C(O)=O","id":"LIOTHYRONINE I-125"},{"COMPOUND_QCD":["false"],"CompoundName":["LIOTHYRONINE HYDROCHLORIDE"],"CompoundSynonym":["3,5,3'-TRIIODO-L-THYRONINE HYDROCHLORIDE","3,5,3'-TRIIODOTHYRONINE HYDROCHLORIDE","ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, HYDROCHLORIDE, L-","L-3,5,3'-TRIIODOTHYRONINE HYDROCHLORIDE","L-TRIIODOTHYRONINE HYDROCHLORIDE","LIOTHYRONINE HYDROCHLORIDE","LYOTHYRONIN","THYBON"],"CompoundSmiles":["Cl.N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O"],"SMILES":"Cl.N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O","KeggId":["D08129"],"Unii":["T66DHO0SET"],"ChemSpiderID":["64407"],"Cas":["6138-47-2"],"Completed":["false"],"MOLFILE":"\n  Marvin  11101717160D          \n\n 24 24  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  3  0  0  0\n  6  7  1  0  0  0  0\n  7  8  1  0  0  0  0\n  7  9  2  3  0  0  0\n  9 10  1  0  0  0  0\n 10 11  1  0  0  0  0\n 11 12  2  3  0  0  0\n 12 13  1  0  0  0  0\n 13 14  2  3  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  2  3  0  0  0\n 11 18  1  0  0  0  0\n  9 19  1  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  2  3  0  0  0\n  5 21  1  0  0  0  0\n  3 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  END\n","id":"LIOTHYRONINE HYDROCHLORIDE","Iupac":["(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid;hydrochloride"],"Cid":["71283"]},{"COMPOUND_QCD":["false"],"CompoundName":["DETROTHYRONINE"],"CompoundSynonym":["D-3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-ALANINE","DETROTHYRONINE","DETROTHYRONINUM","DETROTIRONINA","DT-3","DÉTROTHYRONINE","ДЕТРОТИРОНИН","ديتروثيرونين","右甲状宁"],"CompoundSmiles":["N[C@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O"],"StructureAlert":["true"],"SMILES":"N[C@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O","ChemblId":["CHEMBL557"],"BindingdbId":["50178971"],"Unii":["46XII7C16X"],"ChemSpiderID":["64347"],"Completed":["false"],"MOLFILE":"\n  Marvin  11101717180D          \n\n 23 24  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  2  3  0  0  0\n 13 14  1  0  0  0  0\n 13 15  1  0  0  0  0\n 15 16  1  0  0  0  0\n 15 17  2  3  0  0  0\n 10 17  1  0  0  0  0\n  8 18  1  0  0  0  0\n 18 19  1  0  0  0  0\n 18 20  2  3  0  0  0\n  4 20  1  0  0  0  0\n  2 21  1  0  0  0  0\n 21 22  1  0  0  0  0\n 21 23  2  0  0  0  0\nM  END\n","id":"DETROTHYRONINE","Iupac":["(2R)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid"],"Cid":["71212"]},{"CompoundDescriptionUri":["http://www.drugbank.ca/drugs/DB00451"],"OriginatorUri":["https://books.google.ru/books?id=_J2ti4EkYpkC&pg=PA2044&lpg=PA2044&dq=LEVOTHYROXINE retrieved from Pharmaceutical Manufacturing Encyclopedia William Andrew Publishing, p.2044"],"InVitroUseGuide":["Addition of Levothyroxine at concentrations of 100-200 nM rescued rat cerebellar granule neurons (CGNs) from cell death in K5 in a dose-dependent manner. 200 nM T4 was also effective in maintaining the neurites of CGNs in K5."],"ModifiedDateTime":["2016-10-12"],"Cns":["CNS Penetrant"],"InVitroUri":["https://www.ncbi.nlm.nih.gov/pubmed/25447738"],"ChemblId":["CHEMBL1624"],"OriginatorComment":["Introduced as Synthroid by Flint, US, in 1953"],"Conditions":["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","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"],"ChemSpiderID":["5614"],"InVivoUseGuide":["Usual Adult Dose for Hypothyroidism Average full replacement dose: 1.7 mcg/kg/day (e.g., 100 to 125 mcg/day for a 70 kg adult) orally Older patients may require less than 1 mcg/kg/day"],"Originator":["Flint, US"],"id":"LEVOTHYROXINE","CnsUri":["https://www.ncbi.nlm.nih.gov/pubmed/25206902"],"Cid":["5819"],"COMPOUND_QCD":["false"],"Pmids":["11762711","11759078","11747284","11743520","11740067","11739018","11735863","11725614","11722306","11717046","11716045","11716044","11713551","11712661","11687834","11682905","11665469","11598378","11596688","11592730","11592446","11580995","11577451","11573381","11569180","11563956","11561329","11551989","11549657","11549198","11525272","11525269","11525268","11523623","11515339","11506275","11482411","11476769","11469663","11456264","11454085","11452649","11452512","11445776","11442003","11429671","11425850","11421567","11421125","11420510","11419101","11416978","11414169","11396710","11386017","11377052","11372885","11368519","11367890","11360733","11355292","11349841","11349839","11346056","11335778","11335753","11332254","11332250","11327617","11327616","11326441","11308050","11303890","11293951","11292518","11288989","11288928","11283432","11263673","11256036","11254240","11251705","11250763","11238494","11238476","11234312","11216009","11213935","11207644","11204698","11177166","11169498","11160978","11137975","11108274","10869457","10631123","10580751","10393316","10381190","10072899"],"CompoundName":["LEVOTHYROXINE"],"CompoundSynonym":["(-)-3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE","3,5,3',5'-TETRAIODO-L-THYRONINE","L-THYROXINE","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-","LEVOTHYROXINE","O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-L-TYROSINE","SYNTHETIC LEVOTHYROXINE","T4","THYROXINE","THYROXINE, L-","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT","LEVOTHYROXINE SODIUM","LEVOTHYROXINE SODIUM ANHYDROUS","LEVOTHYROXINUM NATRICUM","LEVOTIROXINA DE SODIO","LÉVOTHYROXINE SODIQUE","THYROXINE SODIUM","THYROXINE SODIUM SALT","ЛЕВОТИРОКСИН НАТРИЯ","ليفوثيروكسين صوديوم","左甲状腺素钠","3',3,5',5-TETRAIODO-L-THYRONINE SODIUM SALT PENTAHYDRATE","ALANINE, 3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)-, MONOSODIUM SALT, PENTAHYDRATE, L-","EFEROX","ELTROXIN","EUTHYROX","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT, HYDRATE","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT, PENTAHYDRATE","L-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, SODIUM SALT, HYDRATE (1:1:5)"],"CompoundSmiles":["N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O"],"InVivoUri":["https://www.drugs.com/dosage/levothyroxine.html"],"StructureAlert":["true"],"Targets":["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","eyJQcmltYXJ5UG90ZW5jeVR5cGUiOiJVbmtub3duIiwiQ29uZGl0aW9uUmVmcyI6WyI1NDNlOTQ2MDU1Il0sIlByaW1hcnlUYXJnZXRUeXBlIjoiQ2hFTUJMIiwiUHJpbWFyeVRhcmdldFVyaSI6Imh0dHA6Ly93d3cuZHJ1Z2JhbmsuY2EvZHJ1Z3MvREIwMDQ1MSIsIlByaW1hcnlQb3RlbmN5VXJpIjoiaHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjMxMTIwNzkiLCJQcmltYXJ5VGFyZ2V0SWQiOiJDSEVNQkwxODYwIiwiVGFyZ2V0UGhhcm1hY29sb2d5IjoiQWdvbmlzdCIsImlkIjoiNDcwNTFlNDI0YiIsIlByaW1hcnlUYXJnZXRMYWJlbCI6IlRoeXJvaWQgaG9ybW9uZSByZWNlcHRvciBhbHBoYSJ9"],"SMILES":"N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","KeggId":["D00361"],"BindingdbId":["50301375"],"Unii":["Q51BO43MG4","054I36CPMN","9J765S329G","B82379R9W0"],"Cas":["51-48-9"],"CompoundDescriptionComment":["Description was created based on several sources, including https://www.drugs.com/dosage/levothyroxine.html"],"Completed":["true"],"MOLFILE":"\n  Marvin  11101717200D          \n\n 24 25  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  1  0  0  0  0\n 12 14  2  3  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  2  3  0  0  0\n 10 18  1  0  0  0  0\n  8 19  1  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  2  3  0  0  0\n  4 21  1  0  0  0  0\n  2 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  END\n","InVivoUseRoute":["Oral"],"Iupac":["(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid"],"CompoundPatent":["5688921","JPS62180269A","JPS59193357A","JPS551590A","JPH09225019A","JPH08107787A","JPH07146293A","JP4709379B2","JP2013256521A","JP2011506995A","JP2005172838A","JP2004515280A","JP2004043443A"],"CompoundDescription":["Levothyroxine (T4) is a synthetically prepared levo isomer of thyroxine, the major hormone secreted from the thyroid gland. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine (T3) which exerts a broad spectrum of stimulatory effects on cell metabolism. Thyroid hormone increases the metabolic rate of cells of all tissues in the body. In the fetus and newborn, thyroid hormone is important for the growth and development of all tissues including bones and the brain. In adults, thyroid hormone helps to maintain brain function, food metabolism, and body temperature, among other effects. The symptoms of thyroid deficiency relieved by levothyroxine include slow speech, lack of energy, weight gain, hair loss, dry thick skin and unusual sensitivity to cold. Levothyroxine acts like the endogenous thyroid hormone thyroxine (T4, a tetra-iodinated tyrosine derivative). In the liver and kidney, T4 is converted to T3, the active metabolite. In order to increase solubility, the thyroid hormones attach to thyroid hormone binding proteins, thyroxin-binding globulin, and thyroxin-binding prealbumin (transthyretin). Transport and binding to thyroid hormone receptors in the cytoplasm and nucleus then takes place. Thus by acting as a replacement for natural thyroxine, symptoms of thyroxine deficiency are relieved. Levothyroxine  is used for use alone or in combination with antithyroid agents to treat hypothyroidism, goiter, chronic lymphocytic thyroiditis, myxedema coma, and stupor."]},{"CompoundDescriptionUri":["https://www.drugbank.ca/drugs/DB00509"],"InVitroUseGuide":["The relative binding affinities of liothyronine (L-T3), levothyroxine (L-T4),  D-triiodothyronine (D-T3), and dextrothyroxine (D-T4) were measured in vitro. Solubilized nuclear receptors were prepared from rat anterior pituitaries. L-T3 had the highest binding for the nuclear receptor (taken as 100%). L-T4 and D-T3 binded to the nuclear receptor with similar affinities (11% and 13%, respectively), while the affinity of D-T4 represents only 3% that of L-T3."],"OriginatorUri":["Unknown"],"ModifiedDateTime":["2017-01-25"],"Cns":["Unknown"],"InVitroUri":["https://www.ncbi.nlm.nih.gov/pubmed/6777394"],"ChemblId":["CHEMBL559"],"OriginatorComment":["Lyon, D. M. Notes on physiological test of synthetic thyroxime. Biochem. J. 21: 181–183, 1927."],"Conditions":["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"],"ChemSpiderID":["8402"],"InVivoUseGuide":["Unknown"],"Originator":["Lyon, D.M."],"id":"DEXTROTHYROXINE","CnsUri":["Unknown"],"Cid":["8730"],"Wikiurl":["https://en.wikipedia.org/wiki/Dextrothyroxine"],"COMPOUND_QCD":["false"],"Pmids":["934018","6777394","5818672","2492189","21701618","21035598","20483419","20020587","18969581","18428182","18373914","18363280","18302516","15932927","15033424","12468267","11901210"],"CompoundName":["DEXTROTHYROXINE"],"CompoundSynonym":["D-THYROXINE","D-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-","DEXTROTHYROXINE","CHOLOXIN","D-TYROSINE, O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT, HYDRATE","DEXTROTHYROXINE SODIUM","DEXTROTHYROXINE SODIUM HYDRATE","MONOSODIUM D-THYROXINE HYDRATE","THYROXINE, MONOSODIUM SALT, HYDRATE, D-","ANHYDROUS DEXTROTHYROXINE SODIUM","D-THYROXINE SODIUM SALT","DEXTROTHYROXINE SODIQUE","DEXTROTHYROXINE SODIUM ANHYDROUS","DEXTROTHYROXINUM NATRICUM","DEXTROTIROXINA DE SODIO","ДЕКСТРОТИРОКСИН НАТРИЯ","ديكستروثيروكسين صوديوم","右甲状腺素钠","D THYROXIN","D-T4 THYROID HORMONE","DEXTROTIROXINA SODICA","SODIUM (2R)-2-AMINO-3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)PROPANOATE HYDRATE","SODIUM DEXTROTHYROXINE","CHEMBL559","CHEMBL1200777"],"CompoundSmiles":["N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O"],"InVivoUri":["Unknown"],"StructureAlert":["true"],"Targets":["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"],"SMILES":"N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","KeggId":["D03750"],"BindingdbId":["50225220"],"Unii":["4W9K63FION","0H00N2AHSP","J60FX7V025"],"Cas":["51-49-0"],"CompoundDescriptionComment":["description was created based on several sources, including https://www.ncbi.nlm.nih.gov/mesh/68003918"],"Completed":["true"],"MOLFILE":"\n  Marvin  11101717200D          \n\n 24 25  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  1  0  0  0  0\n 12 14  2  3  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  2  3  0  0  0\n 10 18  1  0  0  0  0\n  8 19  1  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  2  3  0  0  0\n  4 21  1  0  0  0  0\n  2 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  END\n","DrugbankId":["DB00509"],"InVivoUseRoute":["Oral"],"Iupac":["(2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid"],"CompoundPatent":["US2925364","US20110136911"],"CompoundDescription":["Dextrothyroxine is the dextrorotary isomer of the synthetic thyroxine. It is an antihyperlipidemic agent. The mechanism of action is not completely understood, but dextrothyroxine apparently acts in the liver to stimulate formation of low-density lipoprotein (LDL) and, to a much greater extent, to increase catabolism of LDL. This leads to increased excretion of cholesterol and bile acids via the biliary route into the feces, with a resulting reduction in serum cholesterol and LDL. Dextrothyroxine has no significant effect on high-density lipoproteins (HDL). Inherently, it will also bind to thyroid receptors and as it is a prohormone, it will bind as a substrate to iodide peroxidase."]},{"COMPOUND_QCD":["false"],"Unii":["GCA9VV7D2N"],"CompoundName":["LIOTHYRONINE SODIUM"],"CompoundSynonym":["T3 SODIUM SALT","TERTROXIN","3,3',5-TRIIODO-L-THYRONINE SODIUM SALT","ALANINE, 3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-, MONOSODIUM SALT, L-","BASOPROCIN","CYNOMEL","CYTOBIN","CYTOMEL","IBIOTHYRON","LIOTHYRONINE SODIUM [EP]","LIOTHYRONINE SODIUM [GREEN BOOK]","LIOTHYRONINE SODIUM [MART.]","LIOTHYRONINE SODIUM [ORANGE BOOK]","LIOTHYRONINE SODIUM SALT [MI]","LIOTHYRONINE SODIUM [USP]","LIOTHYRONINE SODIUM [VANDF]","LIOTHYRONINE SODIUM [WHO-DD]","L-TRIIODOTHYRONINE SODIUM SALT","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, SODIUM SALT (1:1)","MONOSODIUM L-3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE","RATHYRONINE SODIUM, (S)-","TRIIODOTHYRONINE SODIUM SALT","TRIOSTAT"],"Cas":["55-06-1"],"CompoundSmiles":["N[C@@H](CC1=CC(=C(OC2=CC=C(O)C(=C2)I)C(=C1)I)I)C([O-])=O"],"Completed":["false"],"MOLFILE":"\n  Marvin  11101717210D          \n\n 23 24  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  2  3  0  0  0\n  7  8  1  0  0  0  0\n  8  9  1  0  0  0  0\n  9 10  2  3  0  0  0\n 10 11  1  0  0  0  0\n 11 12  2  3  0  0  0\n 12 13  1  0  0  0  0\n 12 14  1  0  0  0  0\n 14 15  2  3  0  0  0\n  9 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n  7 17  1  0  0  0  0\n 17 18  2  3  0  0  0\n  4 18  1  0  0  0  0\n 17 19  1  0  0  0  0\n  6 20  1  0  0  0  0\n  2 21  1  0  0  0  0\n 21 22  1  0  0  0  0\n 21 23  2  0  0  0  0\nM  CHG  1  22  -1\nM  END\n","SMILES":"N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C([O-])=O","id":"LIOTHYRONINE SODIUM"},{"CompoundDescriptionUri":["https://www.ncbi.nlm.nih.gov/pubmed/6617571"],"InVitroUseGuide":["The relative affinity of the rat synaptosomes for various T3 analogs was measured by incubating [3H]T3 with increasing amounts of T3, D-T3, T4, TRIAC and rT3, The results were expressed as the molar ratio of the concentrations of T3 or analog needed to decreaseby 50% the binding of [3H]T3."],"OriginatorUri":["https://www.ncbi.nlm.nih.gov/pubmed/14909477"],"ModifiedDateTime":["2017-04-23"],"Cns":["CNS Active"],"InVitroUri":["https://www.ncbi.nlm.nih.gov/pubmed/1606687"],"ChemblId":["CHEMBL789"],"Conditions":["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"],"ChemSpiderID":["838"],"InVivoUseGuide":["Unknown"],"Originator":["Gross J., Pitt-Rivers R."],"id":"RATHYRONINE","CnsUri":["https://www.ncbi.nlm.nih.gov/pubmed/27852726"],"Cid":["861"],"COMPOUND_QCD":["false"],"Pmids":["16293703"],"CompoundName":["RATHYRONINE"],"CompoundSynonym":["DL-3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE","LIOTHYRONINE, DL-","RATHYRONINE","RATHYRONINUM","RATIRONINA","РАТИРОНИН","راثيرونين","雷甲状宁"],"CompoundSmiles":["NC(CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O"],"InVivoUri":["Unknown"],"StructureAlert":["true"],"Targets":["eyJQcmltYXJ5UG90ZW5jeUNvbW1lbnQiOiJEYXRhIGZvciBMaW90aHlyb25pbmUgKEwtVHJpaW9kb3RoeXJvbmluZSkiLCJQcmltYXJ5UG90ZW5jeVR5cGUiOiJLZCIsIlByaW1hcnlQb3RlbmN5VmFsdWUiOiIwLjEiLCJQcmltYXJ5VGFyZ2V0VHlwZSI6IkNoRU1CTCIsIlByaW1hcnlUYXJnZXRVcmkiOiJodHRwczovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xMjEwOTkxNCIsIlByaW1hcnlQb3RlbmN5VXJpIjoiaHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTIxMDk5MTQiLCJQcmltYXJ5UG90ZW5jeURpbWVuc2lvbnMiOiJuTSIsIlByaW1hcnlUYXJnZXRJZCI6IkNIRU1CTDE4NjAiLCJUYXJnZXRQaGFybWFjb2xvZ3kiOiJBZ29uaXN0IiwiaWQiOiJhYjdlNjE3ODk3IiwiUHJpbWFyeVRhcmdldExhYmVsIjoiVGh5cm9pZCBob3Jtb25lIHJlY2VwdG9yIGFscGhhIn0=","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"],"SMILES":"NC(CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O","Unii":["O48UO55HR0"],"Cas":["3130-96-9"],"CompoundDescriptionComment":["description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/535845","https://www.ncbi.nlm.nih.gov/pubmed/4453291","https://www.ncbi.nlm.nih.gov/pubmed/16179385"],"Completed":["true"],"MOLFILE":"\n  Marvin  11101717220D          \n\n 23 24  0  0  0  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  2  3  0  0  0\n 13 14  1  0  0  0  0\n 13 15  1  0  0  0  0\n 15 16  1  0  0  0  0\n 15 17  2  3  0  0  0\n 10 17  1  0  0  0  0\n  8 18  1  0  0  0  0\n 18 19  1  0  0  0  0\n 18 20  2  3  0  0  0\n  4 20  1  0  0  0  0\n  2 21  1  0  0  0  0\n 21 22  1  0  0  0  0\n 21 23  2  0  0  0  0\nM  END\n","InVivoUseRoute":["Unknown"],"Iupac":["2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid"],"CompoundPatent":["JPH00898682A"],"CompoundDescription":["Rathyronine is racemic mixture of Liothyronine (L-Triiodothyronine) and D-Triiodothyronine. Liothyronine (traid name CYTOMEL®) is a T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than its prohormone thyroxine. D-Triiodothyronine may be used to treatment hyperlipidemia, hypothyroidism, euthyroid goiters, ets. Unfortunately there are limited research related Rathyronine or D-Triiodothyronine activity."]},{"CompoundDescriptionUri":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/10379s47lbl.pdf"],"InVitroUseGuide":["It was examined the involvement of phosphatidyl inositol 3 kinase (PI3K) pathway in mediating liothyronine (T3) effects by treating 3T3-L1 adipocytes with physiological (P=10 nM) or supraphysiological (SI=100 nM) T3 doses during one hour, in the absence or the presence of PI3K inhibitor (LY294002). The absence of any treatment was considered the control group (C). T3 increased thyroid hormone receptor alpha (TRa) mRNA expression in P (1.91+/-0.13, p<0.001), SI (2.14+/-0.44, p<0.001) compared to C group (1+/-0.08). This increase was completely abrogated by LY294002 in P (0.53+/-0.03, p<0.001) and SI (0.31+/-0.03, p<0.001). To examine whether TRa is directly induced by T3, the translation inhibitor cycloheximide (CHX) was used. The presence of CHX completely abrogated levels TRa mRNA in P (1.15+/-0.05, p>0.001) and SI (0.99+/-0.15, p>0.001), induced by T3."],"OriginatorUri":["https://www.ncbi.nlm.nih.gov/pubmed/14909477"],"ModifiedDateTime":["2017-04-23"],"Cns":["CNS Active"],"InVitroUri":["https://www.ncbi.nlm.nih.gov/pubmed/25465606"],"ChemblId":["CHEMBL1544"],"Conditions":["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","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","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"],"ChemSpiderID":["5707"],"InVivoUseGuide":["Mild Hypothyroidism: Recommended starting dosage is 25 mcg daily. Daily dosage then may be increased by up to 25 mcg every 1 or 2 weeks. Usual maintenance dose is 25 to 75 mcg daily. Myxedema: Recommended starting dosage is 5 mcg daily. This may be increased by 5 to 10 mcg daily every 1 or 2 weeks. When 25 mcg daily is reached, dosage may be increased by 5 to 25 mcg every 1 or 2 weeks until a satisfactory therapeutic response is attained. Usual maintenance dose is 50 to 100 mcg daily. Congenital Hypothyroidism: Recommended starting dosage is 5 mcg daily, with a 5 mcg increment every 3 to 4 days until the desired response is achieved.  Simple (non-toxic) Goiter: Recommended starting dosage is 5 mcg daily. This dosage may be increased by 5 to 10 mcg daily every 1 or 2 weeks. When 25 mcg daily is reached, dosage may be increased every week or two by 12.5 or 25 mcg. Usual maintenance dosage is 75 mcg daily."],"Originator":["Gross J., Pitt-Rivers R."],"id":"LIOTHYRONINE","CnsUri":["https://www.ncbi.nlm.nih.gov/pubmed/27852726"],"Cid":["5920"],"Wikiurl":["https://en.wikipedia.org/wiki/Liothyronine"],"COMPOUND_QCD":["false"],"Pmids":["11280709","11280679","11278601","11277884","11275680","11274156","11273733","11272100","11270884","11270783","11263673","11263474","11259861","11258898","11258455","11257722","11254240","11253148","11250661","11250652","11250650","11250536","11247916","11247618","11246122","11245686","11245393","11241663","11241400","11241174","11240884","11238502","11238494","11238485","11238313","11234631","11233902","11233497","11231986","11229803","11229503","11227726","11227037","11226744","11222747","11222741","11215679","11211567","11207942","11204719","11204698","11201846","11191079","11179199","11179190","11179038","11178887","11178882","11172894","11172193","11171659","11171071","11168650","11167935","11167931","11167929","11166358","11165746","11165050","11163358","11163315","11162988","11159836","11158928","11152480","11145595","11145578","11145561","11145560","11137975","11135445","11134019","11133928","11123391","11120670","11106433","11099489","11090638","11083869","11077070","11035025","11027684","11017775","11007966","10720163","10580751","10393316","10357836","10217540","10209562","10197073"],"CompoundName":["LIOTHYRONINE"],"CompoundSynonym":["LIOTHYRONINE","CYNOMEL","CYTOBIN","CYTOMEL","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-, MONOSODIUM SALT","LIOTHYRONINE SODIUM","LIOTHYRONINE SODIUM SALT","MONOSODIUM L-3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE","TERTROXIN","TRIOSTAT","3,5,3'-TRIIODOTHYRONINE, L-","LEVOTHYROXINE SODIUM IMPURITY, LIOTHYRONINE-","LEVOTHYROXINE SODIUM SPECIFIED IMPURITY A","LIOTHYRONINUM","LIOTIRONINA","O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-L-TYROSINE","T3","TRIIODOTHYRONINE","ЛИОТИРОНИН","ليوثيرونين","碘塞罗宁","(2S)-2-AMINO-3-[4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL]PROPANOIC ACID","3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)-ALANINE, D-","DETROTHYRONINE","DETROTHYRONINUM","DETROTIRONINA","DEXTRONINE","L-LIOTHYRONINE","L-TYROSINE, O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-","LIOTHYRONIN","LIOTHYRONINE I 125","LIOTHYRONINE I 131","LIOTHYRONINE I-125","LIOTHYRONINE I-131"],"CompoundSmiles":["[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C([O-])=O"],"InVivoUri":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/10379s47lbl.pdf"],"StructureAlert":["true"],"Targets":["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","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"],"SMILES":"[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C([O-])=O","KeggId":["D00361"],"BindingdbId":["18860"],"Unii":["GCA9VV7D2N","06LU7C9H1V"],"Cas":["55-06-1"],"CompoundDescriptionComment":["description was created based on several sources, including https://www.ncbi.nlm.nih.gov/mesh/68014284"],"Completed":["true"],"MOLFILE":"\n  Marvin  11101717220D          \n\n 24 24  0  0  1  0            999 V2000\n    0.0000    0.0000    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  3  0  0  0\n  6  7  1  0  0  0  0\n  7  8  1  0  0  0  0\n  7  9  2  3  0  0  0\n  9 10  1  0  0  0  0\n 10 11  1  0  0  0  0\n 11 12  2  3  0  0  0\n 12 13  1  0  0  0  0\n 13 14  2  3  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  2  3  0  0  0\n 11 18  1  0  0  0  0\n  9 19  1  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  2  3  0  0  0\n  5 21  1  0  0  0  0\n  3 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  CHG  2   1   1  23  -1\nM  END\n","DrugbankId":["DB00279"],"InVivoUseRoute":["Oral"],"Iupac":["(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid"],"CompoundPatent":["JPH0387174A","US20060246133","US2823164"],"CompoundDescription":["Liothyronine (CYTOMEL®) is a T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than its prohormone thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. The mechanisms by which thyroid hormones exert their physiologic action are not well understood. These hormones enhance oxygen consumption by most tissues of the body, increase the basal metabolic rate and the metabolism of carbohydrates, lipids and proteins. Thus, they exert a profound influence on every organ system in the body and are of particular importance in the development of the central nervous system. Thyroid hormone drugs are indicated: as replacement or supplemental therapy in patients with hypothyroidism of any etiology; as pituitary thyroid-stimulating hormone (TSH) suppressants, in the treatment or prevention of various types of euthyroid goiters; as diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy."]},{"CompoundDescriptionUri":["https://www.ncbi.nlm.nih.gov/pubmed/7942274"],"InVitroUseGuide":["Changes in catalase, superoxide dismutase (SOD) and caspase activity, genomic DNA, and nitric oxide (NO) generation were investigated biochemically using Rana japonica tadpole tails undergoing regression during thyroid hormone enhancement. DNA fragmentation and ladder formation with concomitant shortening of tadpole tail were induced by DL-thyroxine (T4) in culture medium. Catalase activity was also decreased by T4 treatment. T4 was also found to increase NO synthase (NOS) activity in cultured tadpole tail with concomitant increase in the concentration of NO2- plus NO3- (NOx) in the culture medium. Additional treatment with N-monomethyl-L-arginine (NMMA), a potent inhibitor of NOS, suppressed the enhancing effects of T4 on tail shortening and catalase activity reduction. These results suggested that T4 enhances NO generation, thereby strongly inhibiting catalase activity, resulting in an increase in hydrogen peroxide, and that the oxidative stress elicited by excess hydrogen peroxide might activate cysteine-dependent aspartate-directed protease-3 (caspase-3-like protease), which is thought to cause DNA fragmentation, leading to apoptosis."],"OriginatorUri":["Unknown"],"ModifiedDateTime":["2017-05-28"],"Cns":["Unknown"],"InVitroUri":["https://www.ncbi.nlm.nih.gov/pubmed/10232845"],"ChemblId":["CHEMBL42115"],"Conditions":["eyJpc0NvbmRpdGlvbk1lc2hJbXByZWNpc2UiOmZhbHNlLCJpc0NvbmRpdGlvbkRvSW1wcmVjaXNlIjpmYWxzZSwiaWQiOiI3ODEwYzViNmIxIiwiQ29uZGl0aW9uTWFudWFsUHJvZHVjdE5hbWUiOmZhbHNlLCJDb25kaXRpb25OYW1lIjoiVW5rbm93biJ9"],"ChemSpiderID":["830"],"InVivoUseGuide":["Unknown"],"Originator":["Unknown"],"id":"THYROXINE, DL-","CnsUri":["Unknown"],"Cid":["853"],"COMPOUND_QCD":["false"],"Pmids":["11272100","11270783","11269756","11268721","11265259","11264481","11263474","11260633","11259861","11258898","11258455","11257722","11256524","11256036","11254486","11254240","11251705","11250765","11250763","11250661","11250652","11250544","11250536","11247916","11247618","11246114","11245393","11243784","11242696","11241400","11238503","11238502","11238494","11238485","11238476","11238475","11234291","11233902","11233880","11233497","11231999","11231986","11229503","11228272","11227731","11227726","11226744","11226638","11225468","11222874","11217063","11216706","11215679","11215080","11213935","11211567","11209999","11208009","11207644","11207634","11204698","11204364","11194689","11182751","11180524","11179199","11179190","11178887","11177016","11174831","11174048","11172218","11172193","11171930","11171659","11170832","11169498","11168451","11167935","11167929","11165746","11165050","11158931","11158928","11158080","11158038","11158026","11148528","11145832","11145743","11145602","11145595","11145561","11139770","11137975","11136194","11135445","11125252","11124146","11123391","11044448"],"CompoundName":["THYROXINE, DL-"],"CompoundSynonym":["(±)-3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE","DL-THYROXINE","O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-DL-TYROSINE","THYROXINE, DL-","THYROXINE","2-AMINO-3-[4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL]PROPANOIC ACID","3,5,3?,5?-TETRAIODO-D-THYRONINE SODIUM","CHOLOXIN","DYNOTHEL","EULIPOS","EUTHROID","EUTHYRAL","LIOTRIX","LIOTRIX (T4","LISOLIPIN","O-(4-HYDROXY-3,5-DIIODOPHENYL)-3,5-DIIODO-L-TYROSINE MIXT. WITH O-(4-HYDROXY-3-IODOPHENYL)-3,5-DIIODO-L-TYROSINE","SODIUM 4-O-(4-HYDROXY-3,5-DI-IODOPHENYL)-3,5-DI-IODO-D-TYROSINATE HYDRATE","THYREOTOM","THYROLAR","THYROXINE - TRIIODOTHYRONINE COMBINATION","THYROXINE - TRIIODOTHYRONINE COMBINATION, MONOSODIUM SALT","TRIIODOTHYRONINE - THYROXINE COMBINATION"],"CompoundSmiles":["NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O"],"InVivoUri":["Unknown"],"StructureAlert":["true"],"SMILES":"NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","Unii":["QR0BV3BRIA"],"Cas":["300-30-1"],"Completed":["true"],"MOLFILE":"\n  Marvin  11101717230D          \n\n 24 25  0  0  0  0            999 V2000\n    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  3  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  2  3  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  2  3  0  0  0\n 11 12  1  0  0  0  0\n 12 13  1  0  0  0  0\n 12 14  2  3  0  0  0\n 14 15  1  0  0  0  0\n 14 16  1  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  2  3  0  0  0\n 10 18  1  0  0  0  0\n  8 19  1  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  2  3  0  0  0\n  4 21  1  0  0  0  0\n  2 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  END\n","InVivoUseRoute":["Unknown"],"Iupac":["2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid"],"CompoundPatent":["JPS62180269A","JPS59193357A","JPS551590A","JPH09225019A","JPH07146293A","JP2011506995A","JP2005172838A","JP2004515280A"],"CompoundDescription":["There is no information related to the pharmacological application of DL-thyroxine, but is known, that this is a mixture of two: L (levothyroxine) and D (dextrothyroxine) forms, and it was shown, that levothyroxine possessed greater antioxidative effect, than the DL."]},{"Synonyms":["Thyroxine I 131","Thyroxine, labeled with iodine-131","Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-131"],"CAS":["7019-69-4"],"REFS":["Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-131|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007019694|USPDDN (United States Pharmacopeia Dictionary of Drug Names)||--Systematic Name--","Thyroxine I 131|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007019694|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|USAN|--Name of Substance--","Thyroxine I 131|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007019694|NLM (National Library of Medicine)||--Synonyms--","Thyroxine, labeled with iodine-131|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007019694|USPDDN (United States Pharmacopeia Dictionary of Drug Names)||--Synonyms--","7019-69-4|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007019694|ChemIDPlus||--CAS Registry Number--","NPC informatics|7019-69-4|NCGC||"],"CURATIONS":["trung|NCGC|trung@jhu.edu||1306585081931","Name!","null!","Thyroxine I 131!","!","Pending!"],"MOLFILE":"Thyroxine I 131\n  Marvin  11101717242D          \n\n 24 25  0  0  1  0            999 V2000\n    0.5954   -2.1656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -2.5781    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   -0.8335   -2.1656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335   -1.3406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -0.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    0.3094    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335    0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335    1.1344    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191    1.5469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    1.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3099    1.5469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.0243    1.1344    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3099    2.3719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.0243    2.7844    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    2.7844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    3.6094    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191    2.3719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.5480   -0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.2625    0.3094    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.5480   -0.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -3.4031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335   -3.8156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954   -3.8156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  1  6  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  1  0  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  1  0  0  0  0\n 11 12  2  0  0  0  0\n 12 13  1  0  0  0  0\n 12 14  1  0  0  0  0\n 14 15  1  0  0  0  0\n 14 16  2  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  1  0  0  0  0\n 10 18  2  0  0  0  0\n  8 19  2  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  1  0  0  0  0\n  4 21  2  0  0  0  0\n  2 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  ISO  4   7 131  13 131  17 131  20 131\nM  END\n","name":"Thyroxine I 131","DATASET":["NPC informatics","INN","ChemIDPlus diffs","Community curation"],"SMILES":"N[C@@H](CC1=CC([131I])=C(OC2=CC([131I])=C(O)C([131I])=C2)C([131I])=C1)C(O)=O","id":"VTQ","ID":["VTQ"]},{"Synonyms":["Sodium (2s)-2-amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoate","Detrothyronine","Liothyronine i-125","Detrothyroninum","Dextronine","Rathyronine","Triiodothyronine","Liothyronine i 131","Monosodium l-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine","Rathyroninum","Liothyronine i 125","3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-alanine, d-","Liothyroninum","Thyroid hormone, t","Detrotironina","Liothyronine","Ratironina","Liothyronine sodium","L-tyrosine, o-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, monosodium salt","3,5,3'-Triiodothyronine, l-","Liothyronine i-131","Cytomel","L-tyrosine, o-(4-hydroxy-3-iodophenyl)-3,5-diiodo-","Liotironina","Tertroxin","Tresitope","Triostat","L-Liothyronine","Liothyronin","Liothyronine Sodium","T3 liothyronine","(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid","Liotrix (Levothyroxine + Liothyronine)","Thyrolar (Levothyroxine + Liothyronine)"],"CompoundCID":["5920","23666110","71212","16760684","861","24867454","23687509"],"CompoundMOA":["Hormones","The hormones, T<sub>4</sub> and T<sub>3</sub>, are tyrosine-based hormones produced by the thyroid gland. Iodine is an important component in their synthesis. The major form of thyroid hormone in the blood is thyroxine (T4). This is converted to the more active liothyronine form by deiodinases in peripheral tissues. Liothyronine acts on the body to increase the basal metabolic rate, affect protein synthesis and increase the body's sensitivity to catecholamines (such as adrenaline). The thyroid hormones are essential to proper development and differentiation of all cells of the human body. To various extents T<sub>4</sub> and T<sub>3</sub> regulate protein, fat and carbohydrate metabolism. Their most pronounced effect is on how human cells use energetic compounds. The thyroid hormone derivatives bind to the thyroid hormone receptors initially to initiate their downstream effects."],"REFS":["L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, monosodium salt|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|EPA SRS (EPA Substance Registry System )||--Systematic Name--","Liothyronine sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|EINECS (EU Inv of Exist.  Comm.  Chem  Sub)||--Systematic Name--","Liothyronine sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|USAN:BAN:JAN|--Name of Substance--","Cytomel|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|Drugs@FDA (FDA Drug Database)||--Synonyms--","Liothyronine sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|Drugs@FDA (FDA Drug Database)||--Synonyms--","Monosodium L-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|USPDDN (United States Pharmacopeia Dictionary of Drug Names)||--Synonyms--","Tertroxin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|NLM (National Library of Medicine)||--Synonyms--","Triostat|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|Drugs@FDA (FDA Drug Database)||--Synonyms--","UNII-GCA9VV7D2N|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|FDA SRS (FDA Substance Registration System)||--Synonyms--","55-06-1|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055061|ChemIDPlus||--CAS Registry Number--","Detrothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0005714089|EINECS (EU Inv of Exist.  Comm.  Chem  Sub)||--Systematic Name--","Detrothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0005714089|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|INN|--Name of Substance--","Detrothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0005714089|NLM (National Library of Medicine)||--Synonyms--","Detrothyroninum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0005714089|NLM (National Library of Medicine)||--Synonyms--","Detrothyroninum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0005714089|NLM (National Library of Medicine)|INN-Latin|--Synonyms--","Detrotironina|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0005714089|NLM (National Library of Medicine)||--Synonyms--","Detrotironina|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0005714089|NLM (National Library of Medicine)|INN-Spanish|--Synonyms--","5714-08-9|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0005714089|ChemIDPlus||--CAS Registry Number--","Liothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|EINECS (EU Inv of Exist.  Comm.  Chem  Sub)||--Systematic Name--","Liothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|FDA SRS (FDA Substance Registration System)||--Name of Substance--","Liothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|INN:BAN|--Name of Substance--","Triiodothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|MeSH (Medical Subject Headings File)||--Name of Substance--","L-Liothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|HSDB (Hazardous Substances Data Bank)||--Synonyms--","L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|HSDB (Hazardous Substances Data Bank)||--Synonyms--","Liothyronin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|HSDB (Hazardous Substances Data Bank)||--Synonyms--","Liothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|MeSH (Medical Subject Headings File)||--Synonyms--","Liothyroninum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|NLM (National Library of Medicine)||--Synonyms--","Liothyroninum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|NLM (National Library of Medicine)|INN-Latin|--Synonyms--","Liotironina|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|NLM (National Library of Medicine)||--Synonyms--","Liotironina|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|NLM (National Library of Medicine)|INN-Spanish|--Synonyms--","Tresitope|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|HSDB (Hazardous Substances Data Bank)||--Synonyms--","Triiodothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|HSDB (Hazardous Substances Data Bank)||--Synonyms--","UNII-06LU7C9H1V|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|FDA SRS (FDA Substance Registration System)||--Synonyms--","Triiodothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|MeSH (Medical Subject Headings File)||--MeSH Heading--","6893-02-3|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|PubMed Toxicology (Toxicology Citations From PubMed)||--CAS Registry Number--","57164-27-9|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Other Registry Number--","7013-53-8|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0006893023|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Other Registry Number--","Rathyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0003130969|EINECS (EU Inv of Exist.  Comm.  Chem  Sub)||--Systematic Name--","Rathyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0003130969|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|INN:DCF|--Name of Substance--","Rathyroninum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0003130969|NLM (National Library of Medicine)||--Synonyms--","Rathyroninum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0003130969|NLM (National Library of Medicine)|INN-Latin|--Synonyms--","Ratironina|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0003130969|NLM (National Library of Medicine)||--Synonyms--","Ratironina|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0003130969|NLM (National Library of Medicine)|INN-Spanish|--Synonyms--","3130-96-9|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0003130969|ChemIDPlus||--CAS Registry Number--","Liothyronine I 131|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0020196649|NLM (National Library of Medicine)|USAN|--Name of Substance--","Liothyronine I 131|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0020196649|NLM (National Library of Medicine)||--Synonyms--","20196-64-9|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0020196649|ChemIDPlus||--CAS Registry Number--","Liothyronine I 125|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0024359146|NLM (National Library of Medicine)|USAN|--Name of Substance--","Liothyronine I 125|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0024359146|NLM (National Library of Medicine)||--Synonyms--","24359-14-6|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0024359146|ChemIDPlus||--CAS Registry Number--","ClinicalTrials.gov||NCGC||","FDA DailyMed||NCGC||","NPC screening|NCGC00096669|NCGC||","Approved drugs||NCGC||","Human approved drugs||NCGC||","FDA approved||NCGC||","NPC informatics|NPC-7294389~Microsource:MS-1502047~National Cancer Institute:NSC-46046~Prestwick:CAS-1823692~Sigma - ALDRICH:MFCD00002593~Sigma - SIGMA:T2877~Sigma - SIGMA:T67407|NCGC||","FDA human approved||NCGC||","HTS amenable drugs||NCGC||HTS amenable drugs","DrugBank v3.0|DB00279|NCGC||","3130-96-9|RATHYRONINE|Tariff||","6893-02-3|Liothyronine|FDA maximum daily dose||","55-06-1|LIOTHYRONINE SODIUM|KEGG||","55-06-1|Liothyronine Sodium|Japan||","LIOTHYRONINE SODIUM|LIOTHYRONINE SODIUM|KEGG||","Liothyronine sodium|LIOTHYRONINE SODIUM|KEGG||","Liothyronine sodium|Liothyronine sodium|UK NHS||","LIOTHYRONINE SODIUM|LIOTHYRONINE SODIUM|FDA orange book||","LIOTHYRONINE SODIUM|TRIOSTAT|FDA orange book||","LIOTHYRONINE SODIUM|CYTOMEL|FDA orange book||","LIOTHYRONINE SODIUM|CYTOMEL|FDA drugs@FDA||","LIOTHYRONINE SODIUM|TRIOSTAT|FDA drugs@FDA||","LIOTHYRONINE SODIUM|LIOTHYRONINE SODIUM|FDA drugs@FDA||","Liothyronine Sodium|Liothyronine Sodium|Japan||","Liothyronine Sodium|Liothyronine Sodium|FDA green book||","LIOTHYRONINE SODIUM|LIOTHYRONINE SODIUM|FDA NDC||","LIOTHYRONINE|CYTOMEL TAB 25MCG|Canada||","LIOTHYRONINE|LIOTHYRONINE|Tariff||","Liothyronine|Liothyronine|FDA maximum daily dose||","LIOTHYRONINE|LIOTHYRONINE|FDA NDC||","RATHYRONINE|RATHYRONINE|Tariff||","DETROTHYRONINE|DETROTHYRONINE|Tariff||","detrothyroninum|detrothyroninum|INN2||","5714-08-9|detrothyroninum|INN2||","liothyroninum|liothyroninum|INN2||","6893-02-3|liothyroninum|INN2||","rathyroninum|rathyroninum|INN2||","3130-96-9|rathyroninum|INN2||"],"CompoundIndication":["Pituitary","Thyroid","Used as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis."],"CURATIONS":["||||1306910354277","Name!","Liothyronine!","Triiodothyronine!","!","Pending!","||||1306891829971","Name!","null!","Liothyronine!","!","Pending!"],"Wikipedia":["http://en.wikipedia.org/wiki/Liothyronine"],"DATASET":["Canada","ClinicalTrials.gov","FDA DailyMed","NPC screening","Approved drugs","FDA maximum daily dose","FDA orange book","Community curation","Human approved drugs","FDA approved","INN","ChemIDPlus diffs","KEGG","FDA NDC","FDA drugs@FDA","FDA green book","NPC informatics","UK NHS","Tariff","FDA human approved","HTS amenable drugs","DrugBank v3.0","Japan"],"SMILES":"NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O","CompoundUNII":["06LU7C9H1V","GCA9VV7D2N"],"CAS":["55-06-1","5714-08-9","57164-27-9","6893-02-3","7013-53-8","6138-47-2","3130-96-9","20196-64-9","24359-14-6","15785-49-6","41670-36-4"],"CLINICALTRIALS":["NCT00223158","NCT00531713"],"MOLFILE":"Triiodothyronine\n  Marvin  11101717252D          \n\n 23 24  0  0  0  0            999 V2000\n    0.6834   -2.1163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.0311   -2.5288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.7455   -2.1163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.7455   -1.2913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.0311   -0.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.0311   -0.0538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6834    0.3587    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.7455    0.3587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.7455    1.1837    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.0311    1.5962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6834    1.1837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3979    1.5962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3979    2.4212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.1123    2.8337    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6834    2.8337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6834    3.6587    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.0311    2.4212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.4600   -0.0538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.1745    0.3587    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.4600   -0.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.0311   -3.3538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.7455   -3.7663    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6834   -3.7663    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  1  0  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  1  0  0  0  0\n 11 12  2  0  0  0  0\n 12 13  1  0  0  0  0\n 13 14  1  0  0  0  0\n 13 15  2  0  0  0  0\n 15 16  1  0  0  0  0\n 15 17  1  0  0  0  0\n 10 17  2  0  0  0  0\n  8 18  2  0  0  0  0\n 18 19  1  0  0  0  0\n 18 20  1  0  0  0  0\n  4 20  2  0  0  0  0\n  2 21  1  0  0  0  0\n 21 22  1  0  0  0  0\n 21 23  2  0  0  0  0\nM  END\n","name":"Triiodothyronine","CompoundDrugLabelRx":["54868-1750;Cytomel;tablet;LIOTHYRONINE SODIUM;25 ug;GCA9VV7D2N 06LU7C9H1V","0179-0018;LIOTHYRONINE SODIUM;tablet;LIOTHYRONINE SODIUM;25 ug;GCA9VV7D2N 06LU7C9H1V","0574-0222;Liothyronine Sodium;tablet;Liothyronine Sodium;25 ug;GCA9VV7D2N 06LU7C9H1V","39822-0151;liothyronine sodium;injection, solution;LIOTHYRONINE SODIUM;10 ug in 1 mL;GCA9VV7D2N 06LU7C9H1V","0378-3611;Liothyronine sodium;tablet;LIOTHYRONINE SODIUM;5 ug;GCA9VV7D2N 06LU7C9H1V","16590-303;Liothyronine Sodium;tablet;Liothyronine Sodium;50 1;GCA9VV7D2N 06LU7C9H1V","0574-0220;Liothyronine Sodium;tablet;Liothyronine Sodium;5 ug;GCA9VV7D2N 06LU7C9H1V","0378-3612;Liothyronine sodium;tablet;LIOTHYRONINE SODIUM;25 ug;GCA9VV7D2N 06LU7C9H1V","60793-117;Cytomel;tablet;LIOTHYRONINE SODIUM;50 ug;GCA9VV7D2N 06LU7C9H1V","0574-0223;Liothyronine Sodium;tablet;Liothyronine Sodium;50 ug;GCA9VV7D2N 06LU7C9H1V","60793-115;Cytomel;tablet;LIOTHYRONINE SODIUM;5 ug;GCA9VV7D2N 06LU7C9H1V","0378-3613;Liothyronine sodium;tablet;LIOTHYRONINE SODIUM;50 ug;GCA9VV7D2N 06LU7C9H1V","43063-252;Liothyronine Sodium;tablet;Liothyronine Sodium;50 ug;GCA9VV7D2N 06LU7C9H1V","54868-5058;Cytomel;tablet;LIOTHYRONINE SODIUM;5 ug;GCA9VV7D2N 06LU7C9H1V","0179-0019;LIOTHYRONINE SODIUM;tablet;LIOTHYRONINE SODIUM;5 ug;GCA9VV7D2N 06LU7C9H1V","43063-253;Liothyronine Sodium;tablet;Liothyronine Sodium;25 ug;GCA9VV7D2N 06LU7C9H1V","42023-120;Triostat;injection;liothyronine sodium;10 ug in 1 mL;GCA9VV7D2N 06LU7C9H1V","60793-116;Cytomel;tablet;LIOTHYRONINE SODIUM;25 ug;GCA9VV7D2N 06LU7C9H1V","0456-0045;Thyrolar;tablet;Liothyronine Sodium;6.25 ug in 1 TABLET;GCA9VV7D2N 06LU7C9H1V","0456-0055;Thyrolar;tablet;Liothyronine Sodium;25 ug in 1 TABLET;GCA9VV7D2N 06LU7C9H1V","0456-0040;Thyrolar;tablet;Liothyronine Sodium;3.1 ug in 1 TABLET;GCA9VV7D2N 06LU7C9H1V","60793-721;Triostat;injection;liothyronine sodium;10 ug in 1 mL;GCA9VV7D2N 06LU7C9H1V","0456-0050;Thyrolar;tablet;Liothyronine Sodium;12.5 ug in 1 TABLET;GCA9VV7D2N 06LU7C9H1V","0456-0060;Thyrolar;tablet;Liothyronine Sodium;37.5 ug in 1 TABLET;GCA9VV7D2N 06LU7C9H1V"],"TARGETS":["Thyroid hormone receptor alpha (THA_HUMAN)|Homo sapiens|~THRA~EAR7~ERBA1~NR1A1~THRA1~THRA2|P10827|A8K3B5|P21205|Q8N6A1|Q96H73","Thyroid hormone receptor beta (THB_HUMAN)|Homo sapiens|~THRB~ERBA2~NR1A2~THR1|P10828|B3KU79|P37243|Q13986|Q3KP35|Q6WGL2|Q9UD41"],"ID":["RHQ"],"id":"RHQ"},{"Synonyms":["Levothyroxine","Levothyroxine sodium - liothyronine sodium","Levothyroxine sodium","Synthroid","Levothyroxinum natricum","Liotrix (t4","Levothyroxine sodique","Levoxyl","Levothyroxine, anhydrous","Levothroid","Thyradin","Levotiroxina sodica","Eltroxin","Euthyrox","Laevoxin","Letter","Levaxin","Levolet","Levothyrox","Levoxine","Novothyrox","Oroxine","Synthroid Sodium","Thyratabs","Thyrax","Thyreoideum","Thyro-tabs","Thyroxevan","Thyroxin","Thyroxinal","Unithroid","(-)-Thyroxine","3,3',5,5'-Tetraiodo-L-thyronine","L-Thryoxin","L-Thyroxine","Laevothyroxinum","Levo-t","Levothyroxin","Levothyroxine Sodium","O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine","T4 levothyroxine","THX","Tetraiodothyronine","Thyroxine iodine","(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid","Liotrix (Levothyroxine + Liothyronine)","Thyrolar (Levothyroxine + Liothyronine)","Bitiron","Combithyrex","Cynoplus","Dithyron","Euthroid","Euthyral","Eutroid","Levotiroxina","Levotrin","Novothyral","Novotiral","Prothyrid","Thyreotom","Thyrolar","Tiroide Amsa","Tyroplus","Liotrix","disodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate","Thyroxine I 125","Tetramet","Thyroxine, labeled with iodine-125","Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-125"],"CompoundCID":["5819","8730","853","71371"],"CompoundMOA":["Hormones","Levothyroxine acts like the endogenous thyroid hormone thyroxine (T<sub>4</sub>, a tetra-iodinated tyrosine derivative). In the liver and kidney, T<sub>4</sub> is converted to T<sub>3</sub>, the active metabolite. In order to increase solubility, the thyroid hormones attach to thyroid hormone binding proteins, thyroxin-binding globulin, and thyroxin-binding prealbumin (transthyretin). Transport and binding to thyroid hormone receptors in the cytoplasm and nucleus then takes place. Thus by acting as a replacement for natural thyroxine, symptoms of thyroxine deficiency are relieved.","The hormones, T<sub>4</sub> and T<sub>3</sub>, are tyrosine-based hormones produced by the thyroid gland. Iodine is an important component in their synthesis. The major secreted form of thyroid hormone is T4. T4 is converted T3, the more active thyroid hormone, by deiodinases in peripheral tissues. T3 acts in the body to increase basal metabolic rate, alter protein synthesis and increase the body's sensitivity to catecholamines (such as adrenaline). Thyroid hormones are essential for proper development and differentiation of all cells of the human body. T<sub>4</sub> and T<sub>3</sub> regulate protein, fat and carbohydrate metabolism to varying extents. The most pronounced effect of the hormones is in altering how human cells use energetic compounds. The thyroid hormone derivatives bind to the thyroid hormone receptors initially to initiate their downstream effects."],"REFS":["Liotrix|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|USAN|--Name of Substance--","Combithyrex|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Euthroid|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Liotrix|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Novothyral|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Thyrolar|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","8065-29-0|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|ChemIDPlus||--CAS Registry Number--","Levothyroxine sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|EINECS (EU Inv of Exist.  Comm.  Chem  Sub)||--Systematic Name--","Eltroxin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Euthyrox|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Laevoxin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Letter|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Levaxin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Levo-T|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|Drugs@FDA (FDA Drug Database)||--Synonyms--","Levolet|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|Drugs@FDA (FDA Drug Database)||--Synonyms--","Levothroid|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|Drugs@FDA (FDA Drug Database)||--Synonyms--","Levothyroxine sodique|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|NLM (National Library of Medicine)||--Synonyms--","Levothyroxine sodique|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|NLM (National Library of Medicine)|INN-French|--Synonyms--","Levothyroxine sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|Drugs@FDA (FDA Drug Database)||--Synonyms--","Levothyroxinum natricum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|NLM (National Library of Medicine)||--Synonyms--","Levothyroxinum natricum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|NLM (National Library of Medicine)|INN-Latin|--Synonyms--","Levotiroxina sodica|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|NLM (National Library of Medicine)||--Synonyms--","Levotiroxina sodica|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|NLM (National Library of Medicine)|INN-Spanish|--Synonyms--","Levoxyl|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|Drugs@FDA (FDA Drug Database)||--Synonyms--","Novothyrox|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|Drugs@FDA (FDA Drug Database)||--Synonyms--","Oroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Synthroid|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|Drugs@FDA (FDA Drug Database)||--Synonyms--","Synthroid sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Thyradin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|NLM (National Library of Medicine)||--Synonyms--","Thyro-Tabs|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|NLM (National Library of Medicine)||--Synonyms--","Thyroxevan|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","UNII-9J765S329G|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|FDA SRS (FDA Substance Registration System)||--Synonyms--","Unithroid|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|Drugs@FDA (FDA Drug Database)||--Synonyms--","Levothyroxine Sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|USAN|--Name of Substance--","55-03-8|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|ChemIDPlus||--CAS Registry Number--","50809-32-0|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|TSCAINV (EPA Chem.  Sub.  Inventory)||--Other Registry Number--","67809-22-7|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|TSCAINV (EPA Chem.  Sub.  Inventory)||--Other Registry Number--","Levothroid|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0025416653|USPDDN (United States Pharmacopeia Dictionary of Drug Names)||--Synonyms--","25416-65-3|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0025416653|ChemIDPlus||--CAS Registry Number--","Levothyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|NLM (National Library of Medicine)|INN|--Name of Substance--","(-)-Thyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|NLM (National Library of Medicine)||--Synonyms--","3,3',5,5'-Tetraiodo-L-thyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|HSDB (Hazardous Substances Data Bank)||--Synonyms--","L-Thyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|EPA SRS (EPA Substance Registry System )||--Synonyms--","Levothyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Synthroid|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|NLM (National Library of Medicine)||--Synonyms--","THX|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|HSDB (Hazardous Substances Data Bank)||--Synonyms--","Tetraiodothyronine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|HSDB (Hazardous Substances Data Bank)||--Synonyms--","Thyratabs|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|NLM (National Library of Medicine)||--Synonyms--","Thyrax|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|NLM (National Library of Medicine)||--Synonyms--","Thyreoideum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|HSDB (Hazardous Substances Data Bank)||--Synonyms--","Thyroxin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|HSDB (Hazardous Substances Data Bank)||--Synonyms--","Thyroxinal|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Thyroxine iodine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|NLM (National Library of Medicine)||--Synonyms--","UNII-Q51BO43MG4|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|FDA SRS (FDA Substance Registration System)||--Synonyms--","51-48-9|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|ChemIDPlus||--CAS Registry Number--","Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-125|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0024486406|USPDDN (United States Pharmacopeia Dictionary of Drug Names)||--Systematic Name--","Thyroxine I 125|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0024486406|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|USAN|--Name of Substance--","Tetramet|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0024486406|USPDDN (United States Pharmacopeia Dictionary of Drug Names)||--Synonyms--","Thyroxine I 125|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0024486406|NLM (National Library of Medicine)||--Synonyms--","Thyroxine, labeled with iodine-125|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0024486406|USPDDN (United States Pharmacopeia Dictionary of Drug Names)||--Synonyms--","24486-40-6|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0024486406|ChemIDPlus||--CAS Registry Number--","Thyradin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008028362|HSDB (Hazardous Substances Data Bank)||--Synonyms--","Levoxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000302012|HSDB (Hazardous Substances Data Bank)||--Synonyms--","Thyroxine iodine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007019694|NLM (National Library of Medicine)||--Synonyms--","Euthyral|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008061583|MeSH (Medical Subject Headings File)||--Synonyms--","Thyreotom|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008061583|MeSH (Medical Subject Headings File)||--Synonyms--","ClinicalTrials.gov||NCGC||","FDA DailyMed||NCGC||","NPC screening|NCGC00164336|NCGC||","Approved drugs||NCGC||","Human approved drugs||NCGC||","FDA approved||NCGC||","NPC informatics|NPC-9299303~24486-40-6~Microsource:MS-1500774~Prestwick:CAS-51-48-9~Sigma - ALDRICH:MFCD00002595~Sigma - SIGMA:234702|NCGC||","FDA human approved||NCGC||","HTS amenable drugs||NCGC||HTS amenable drugs","DrugBank v3.0|DB00451~DB01583|NCGC||","51-48-9|Levothyroxine|FDA maximum daily dose||","25416-65-3|LEVOTHYROXINE SODIUM|KEGG||","25416-65-3|Levothyroxine Sodium|Japan||","55-03-8|LEVOTHYROXINE SODIUM|Tariff||","8065-29-0|LIOTRIX|KEGG||","LIOTRIX|LIOTRIX|KEGG||","Liotrix|LIOTRIX|KEGG||","LEVOTHYROXINE SODIUM|NV-THYRO TAB 0.1 MG|Canada||","LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM|KEGG||","Levothyroxine sodium|LEVOTHYROXINE SODIUM|KEGG||","LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM|Tariff||","LEVOTHYROXINE SODIUM|TIROSINT|FDA orange book||","LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM|FDA orange book||","LEVOTHYROXINE SODIUM|LEVOLET|FDA orange book||","LEVOTHYROXINE SODIUM|LEVO-T|FDA orange book||","LEVOTHYROXINE SODIUM|LEVOTHROID|FDA orange book||","LEVOTHYROXINE SODIUM|LEVOXYL|FDA orange book||","LEVOTHYROXINE SODIUM|NOVOTHYROX|FDA orange book||","LEVOTHYROXINE SODIUM|SYNTHROID|FDA orange book||","LEVOTHYROXINE SODIUM|UNITHROID|FDA orange book||","LEVOTHYROXINE SODIUM|LEVOTHROID|FDA drugs@FDA||","LEVOTHYROXINE SODIUM|LEVOLET|FDA drugs@FDA||","LEVOTHYROXINE SODIUM|UNITHROID|FDA drugs@FDA||","LEVOTHYROXINE SODIUM|NOVOTHYROX|FDA drugs@FDA||","LEVOTHYROXINE SODIUM|LEVOXYL|FDA drugs@FDA||","LEVOTHYROXINE SODIUM|LEVO-T|FDA drugs@FDA||","LEVOTHYROXINE SODIUM|SYNTHROID|FDA drugs@FDA||","LEVOTHYROXINE SODIUM|TIROSINT|FDA drugs@FDA||","LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM|FDA drugs@FDA||","Levothyroxine Sodium|Levothyroxine Sodium|Japan||","LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM|FDA NDC||","levothyroxine|levothyroxine|WHO essential||","Levothyroxine|Levothyroxine|FDA maximum daily dose||","LEVOTHYROXINE|LEVOTHYROXINE|FDA NDC||","levothyroxinum natricum|levothyroxinum natricum|INN2||","55-03-8|levothyroxinum natricum|INN2||"],"CompoundIndication":["Thyroid","For use alone or in combination with antithyroid agents to treat hypothyroidism, goiter, chronic lymphocytic thyroiditis, myxedema coma, and stupor.","May be used to treat primary, secondary or tertiary hypothyroidism. May also be used to suppress thyroid stimulating hormone (TSH) secretion in patients with simple (nontoxic) goiter, subacute or chronic lymphocytic thyroiditis multinodular goiter, and in the management of thyroid cancer. May be used in conjunction with other antithyroid agents to treat thyrotoxicosis to prevent goitrogenesis and hypothyroidism. May also be used for differential diagnosis of suspected mild hyperthyroidism or thyroid gland autonomy."],"CURATIONS":["||||1307010278221","Name!","null!","Levothyroxine!","!","Pending!"],"Wikipedia":["http://en.wikipedia.org/wiki/Levothyroxine"],"DATASET":["Canada","ClinicalTrials.gov","FDA DailyMed","NPC screening","Approved drugs","FDA maximum daily dose","FDA orange book","Community curation","Human approved drugs","WHO essential","FDA approved","INN","ChemIDPlus diffs","KEGG","FDA NDC","FDA drugs@FDA","NPC informatics","FDA human approved","Tariff","HTS amenable drugs","DrugBank v3.0","Japan"],"SMILES":"N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","DOCUMENTS":["341699"],"CompoundUNII":["Q51BO43MG4","9J765S329G"],"CAS":["8065-29-0","55-03-8","67809-22-7","25416-65-3","50809-32-0","51-48-9","24486-40-6"],"CLINICALTRIALS":["NCT00565890","NCT00388297","NCT01189344","NCT00111735","NCT00498238","NCT00524238","NCT00770016"],"MOLFILE":"Levothyroxine\n  Marvin  11101717252D          \n\n 24 25  0  0  1  0            999 V2000\n    0.5954   -2.1656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -2.5781    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   -0.8335   -2.1656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335   -1.3406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -0.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    0.3094    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335    0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335    1.1344    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191    1.5469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    1.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3099    1.5469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.0243    1.1344    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3099    2.3719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.0243    2.7844    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    2.7844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    3.6094    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191    2.3719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.5480   -0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.2625    0.3094    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.5480   -0.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -3.4031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335   -3.8156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954   -3.8156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  1  6  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  1  0  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  1  0  0  0  0\n 11 12  2  0  0  0  0\n 12 13  1  0  0  0  0\n 12 14  1  0  0  0  0\n 14 15  1  0  0  0  0\n 14 16  2  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  1  0  0  0  0\n 10 18  2  0  0  0  0\n  8 19  2  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  1  0  0  0  0\n  4 21  2  0  0  0  0\n  2 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  END\n","name":"Levothyroxine","CompoundDrugLabelRx":["55154-7806;Levoxyl;tablet;levothyroxine sodium;112 ug;9J765S329G Q51BO43MG4","24090-494;Tirosint;capsule;Levothyroxine Sodium;88 ug;9J765S329G Q51BO43MG4","51138-162;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;75 ug;9J765S329G Q51BO43MG4","25121-006;Tirosint;capsule;Levothyroxine Sodium;100 ug;9J765S329G Q51BO43MG4","51138-170;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;200 ug;9J765S329G Q51BO43MG4","0378-1823;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;137 ug;9J765S329G Q51BO43MG4","0456-1326;Levothroid;tablet;levothyroxine sodium;175 ug;9J765S329G Q51BO43MG4","21695-748;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.025 mg;9J765S329G Q51BO43MG4","51138-161;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;50 ug;9J765S329G Q51BO43MG4","25121-008;Tirosint;capsule;Levothyroxine Sodium;125 ug;9J765S329G Q51BO43MG4","0527-1343;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.075 mg;9J765S329G Q51BO43MG4","25121-004;Tirosint;capsule;Levothyroxine Sodium;75 ug;9J765S329G Q51BO43MG4","0074-6624;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;100 ug;9J765S329G Q51BO43MG4","53808-0668;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;125 ug;9J765S329G Q51BO43MG4","55154-0908;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;300 ug;9J765S329G Q51BO43MG4","54868-2539;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;0.075 mg;9J765S329G Q51BO43MG4","21695-750;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.075 mg;9J765S329G Q51BO43MG4","55154-7802;Levoxyl;tablet;levothyroxine sodium;100 ug;9J765S329G Q51BO43MG4","54868-0935;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;0.088 mg;9J765S329G Q51BO43MG4","54868-4092;Levoxyl;tablet;LEVOTHYROXINE SODIUM;0.050 mg;9J765S329G Q51BO43MG4","51138-046;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.137 mg;9J765S329G Q51BO43MG4","51079-443;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;125 ug;9J765S329G Q51BO43MG4","51138-168;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;150 ug;9J765S329G Q51BO43MG4","0074-5182;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;75 ug;9J765S329G Q51BO43MG4","43063-235;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;175 ug;9J765S329G Q51BO43MG4","51138-053;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.175 mg;9J765S329G Q51BO43MG4","21695-758;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.2 mg;9J765S329G Q51BO43MG4","0527-1342;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.05 mg;9J765S329G Q51BO43MG4","53808-0449;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;0.125 mg;9J765S329G Q51BO43MG4","49349-007;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;0.112 mg;9J765S329G Q51BO43MG4","55154-0910;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;25 ug;9J765S329G Q51BO43MG4","0074-6594;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;88 ug;9J765S329G Q51BO43MG4","51138-042;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.075 mg;9J765S329G Q51BO43MG4","51138-040;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.025 mg;9J765S329G Q51BO43MG4","24090-495;Tirosint;capsule;Levothyroxine Sodium;100 ug;9J765S329G Q51BO43MG4","55154-7811;Levoxyl;tablet;levothyroxine sodium;200 ug;9J765S329G Q51BO43MG4","0378-1819;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;200 ug;9J765S329G Q51BO43MG4","42192-331;NP Thyroid 90;tablet;LEVOTHYROXINE;57 ug;Q51BO43MG4","0378-1803;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;50 ug;9J765S329G Q51BO43MG4","0456-1331;Levothroid;tablet;levothyroxine sodium;137 ug;9J765S329G Q51BO43MG4","55154-0903;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;50 ug;9J765S329G Q51BO43MG4","0527-1341;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.025 mg;9J765S329G Q51BO43MG4","54868-1092;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.15 mg;9J765S329G Q51BO43MG4","0527-1346;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.112 mg;9J765S329G Q51BO43MG4","55154-0909;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;125 ug;9J765S329G Q51BO43MG4","54868-1012;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.2 mg;9J765S329G Q51BO43MG4","43063-209;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;88 ug;9J765S329G Q51BO43MG4","0074-4552;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;50 ug;9J765S329G Q51BO43MG4","55154-7801;Levoxyl;tablet;levothyroxine sodium;25 ug;9J765S329G Q51BO43MG4","51079-441;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;75 ug;9J765S329G Q51BO43MG4","54868-3389;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.025 mg;9J765S329G Q51BO43MG4","51079-440;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;50 ug;9J765S329G Q51BO43MG4","25121-009;Tirosint;capsule;Levothyroxine Sodium;137 ug;9J765S329G Q51BO43MG4","54868-1011;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.05 mg;9J765S329G Q51BO43MG4","51138-163;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;88 ug;9J765S329G Q51BO43MG4","55154-0904;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;75 ug;9J765S329G Q51BO43MG4","55154-0905;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;150 ug;9J765S329G Q51BO43MG4","51138-044;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.100 mg;9J765S329G Q51BO43MG4","0456-1329;Levothroid;tablet;levothyroxine sodium;88 ug;9J765S329G Q51BO43MG4","51138-169;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;175 ug;9J765S329G Q51BO43MG4","0074-4341;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;25 ug;9J765S329G Q51BO43MG4","53808-0608;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;100 ug;9J765S329G Q51BO43MG4","54868-4535;Levoxyl;tablet;LEVOTHYROXINE SODIUM;0.15 mg;9J765S329G Q51BO43MG4","25121-001;Tirosint;capsule;Levothyroxine Sodium;13 ug;9J765S329G Q51BO43MG4","51138-049;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.300 mg;9J765S329G Q51BO43MG4","0074-7148;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;200 ug;9J765S329G Q51BO43MG4","51138-043;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.088 mg;9J765S329G Q51BO43MG4","25121-003;Tirosint;capsule;Levothyroxine Sodium;50 ug;9J765S329G Q51BO43MG4","55154-7808;Levoxyl;tablet;levothyroxine sodium;137 ug;9J765S329G Q51BO43MG4","55154-0911;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;112 ug;9J765S329G Q51BO43MG4","0527-1350;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.175  mg;9J765S329G Q51BO43MG4","53808-0447;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;0.075 mg;9J765S329G Q51BO43MG4","54868-4177;Levoxyl;tablet;LEVOTHYROXINE SODIUM;0.088 mg;9J765S329G Q51BO43MG4","55154-0906;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;100 ug;9J765S329G Q51BO43MG4","54868-5671;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.137 mg;9J765S329G Q51BO43MG4","53808-0607;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;75 ug;9J765S329G Q51BO43MG4","54868-2131;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;0.05 mg;9J765S329G Q51BO43MG4","24090-496;Tirosint;capsule;Levothyroxine Sodium;112 ug;9J765S329G Q51BO43MG4","0378-1811;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;112 ug;9J765S329G Q51BO43MG4","0527-1347;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.125 mg;9J765S329G Q51BO43MG4","55154-0914;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;175 ug;9J765S329G Q51BO43MG4","55154-7807;Levoxyl;tablet;levothyroxine sodium;125 ug;9J765S329G Q51BO43MG4","0527-1345;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.1 mg;9J765S329G Q51BO43MG4","51138-041;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.050 mg;9J765S329G Q51BO43MG4","51079-445;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;150 ug;9J765S329G Q51BO43MG4","0456-1322;Levothroid;tablet;levothyroxine sodium;75 ug;9J765S329G Q51BO43MG4","54868-4087;Levoxyl;tablet;LEVOTHYROXINE SODIUM;0.025 mg;9J765S329G Q51BO43MG4","51138-052;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.125 mg;9J765S329G Q51BO43MG4","25121-007;Tirosint;capsule;Levothyroxine Sodium;112 ug;9J765S329G Q51BO43MG4","0456-1325;Levothroid;tablet;levothyroxine sodium;150 ug;9J765S329G Q51BO43MG4","53808-0446;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;0.05 mg;9J765S329G Q51BO43MG4","55154-7809;Levoxyl;tablet;levothyroxine sodium;150 ug;9J765S329G Q51BO43MG4","49349-122;LEVOTHYROXINE SODIUM;tablet;LEVOTHYROXINE SODIUM;0.075 mg;9J765S329G Q51BO43MG4","24090-498;Tirosint;capsule;Levothyroxine Sodium;137 ug;9J765S329G Q51BO43MG4","55154-7803;Levoxyl;tablet;levothyroxine sodium;50 ug;9J765S329G Q51BO43MG4","0074-3727;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;137 ug;9J765S329G Q51BO43MG4","21695-749;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.05 mg;9J765S329G Q51BO43MG4","55154-7804;Levoxyl;tablet;levothyroxine sodium;75 ug;9J765S329G Q51BO43MG4","54868-3069;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.175 mg;9J765S329G Q51BO43MG4","51138-160;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;25 ug;9J765S329G Q51BO43MG4","24090-497;Tirosint;capsule;Levothyroxine Sodium;125 ug;9J765S329G Q51BO43MG4","0527-1352;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.3 mg;9J765S329G Q51BO43MG4","21695-754;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.125 mg;9J765S329G Q51BO43MG4","54868-3849;Levoxyl;tablet;LEVOTHYROXINE SODIUM;0.112 mg;9J765S329G Q51BO43MG4","51079-444;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;25 ug;9J765S329G Q51BO43MG4","53808-0280;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;150 ug;9J765S329G Q51BO43MG4","0378-1817;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;175 ug;9J765S329G Q51BO43MG4","0527-1349;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.15 mg;9J765S329G Q51BO43MG4","54868-3388;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;0.025 mg;9J765S329G Q51BO43MG4","24090-499;Tirosint;capsule;Levothyroxine Sodium;150 ug;9J765S329G Q51BO43MG4","0074-7068;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;125 ug;9J765S329G Q51BO43MG4","54868-2705;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.088 mg;9J765S329G Q51BO43MG4","0527-1351;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.2 mg;9J765S329G Q51BO43MG4","51138-048;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.200 mg;9J765S329G Q51BO43MG4","0456-1327;Levothroid;tablet;levothyroxine sodium;200 ug;9J765S329G Q51BO43MG4","0378-1800;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;25 ug;9J765S329G Q51BO43MG4","24090-492;Tirosint;capsule;Levothyroxine Sodium;50 ug;9J765S329G Q51BO43MG4","54868-4536;Levoxyl;tablet;LEVOTHYROXINE SODIUM;0.125 mg;9J765S329G Q51BO43MG4","0074-9296;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;112 ug;9J765S329G Q51BO43MG4","0527-1638;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.137 mg;9J765S329G Q51BO43MG4","25121-010;Tirosint;capsule;Levothyroxine Sodium;150 ug;9J765S329G Q51BO43MG4","54868-4176;Levoxyl;tablet;LEVOTHYROXINE SODIUM;0.1 mg;9J765S329G Q51BO43MG4","0456-1320;Levothroid;tablet;levothyroxine sodium;25 ug;9J765S329G Q51BO43MG4","25121-005;Tirosint;capsule;Levothyroxine Sodium;88 ug;9J765S329G Q51BO43MG4","43063-230;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;112 ug;9J765S329G Q51BO43MG4","53808-0606;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;175 ug;9J765S329G Q51BO43MG4","25121-002;Tirosint;capsule;Levothyroxine Sodium;25 ug;9J765S329G Q51BO43MG4","54868-2638;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.125 mg;9J765S329G Q51BO43MG4","42192-329;NP Thyroid 30;tablet;LEVOTHYROXINE;19 ug;Q51BO43MG4","55154-7805;Levoxyl;tablet;levothyroxine sodium;88 ug;9J765S329G Q51BO43MG4","42192-330;NP Thyroid 60;tablet;LEVOTHYROXINE;38 ug;Q51BO43MG4","0378-1809;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;100 ug;9J765S329G Q51BO43MG4","0456-1323;Levothroid;tablet;levothyroxine sodium;100 ug;9J765S329G Q51BO43MG4","51138-167;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;137 ug;9J765S329G Q51BO43MG4","0456-1328;Levothroid;tablet;levothyroxine sodium;300 ug;9J765S329G Q51BO43MG4","51138-166;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;125 ug;9J765S329G Q51BO43MG4","54868-0376;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.1 mg;9J765S329G Q51BO43MG4","49349-038;Levothyroxine Sodium;tablet;LEVOTHYROXINE;0.125 mg;Q51BO43MG4","24090-490;Tirosint;capsule;Levothyroxine Sodium;13 ug;9J765S329G Q51BO43MG4","0378-1815;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;150 ug;9J765S329G Q51BO43MG4","54868-0805;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;1 mg;9J765S329G Q51BO43MG4","54868-1506;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.3 mg;9J765S329G Q51BO43MG4","21695-756;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.15 mg;9J765S329G Q51BO43MG4","21695-752;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.1 mg;9J765S329G Q51BO43MG4","0074-7069;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;150 ug;9J765S329G Q51BO43MG4","51079-442;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;100 ug;9J765S329G Q51BO43MG4","0074-7070;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;175 ug;9J765S329G Q51BO43MG4","51138-164;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;100 ug;9J765S329G Q51BO43MG4","0378-1813;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;125 ug;9J765S329G Q51BO43MG4","51138-045;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.112 mg;9J765S329G Q51BO43MG4","0456-1330;Levothroid;tablet;levothyroxine sodium;112 ug;9J765S329G Q51BO43MG4","54868-4534;Levoxyl;tablet;LEVOTHYROXINE SODIUM;0.075 mg;9J765S329G Q51BO43MG4","0378-1807;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;88 ug;9J765S329G Q51BO43MG4","55154-0907;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;200 ug;9J765S329G Q51BO43MG4","0378-1821;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;300 ug;9J765S329G Q51BO43MG4","0074-7149;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;300 ug;9J765S329G Q51BO43MG4","51138-047;LEVOTHYROXINE SODIUM;tablet;Levothyroxine Sodium;0.15 mg;9J765S329G Q51BO43MG4","55154-7810;Levoxyl;tablet;levothyroxine sodium;175 ug;9J765S329G Q51BO43MG4","24090-491;Tirosint;capsule;Levothyroxine Sodium;25 ug;9J765S329G Q51BO43MG4","0378-1805;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;75 ug;9J765S329G Q51BO43MG4","24090-493;Tirosint;capsule;Levothyroxine Sodium;75 ug;9J765S329G Q51BO43MG4","0527-1344;Levothyroxine Sodium;tablet;Levothyroxine Sodium;0.088 mg;9J765S329G Q51BO43MG4","0456-1324;Levothroid;tablet;levothyroxine sodium;125 ug;9J765S329G Q51BO43MG4","53808-0279;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;25 ug;9J765S329G Q51BO43MG4","53808-0605;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;50 ug;9J765S329G Q51BO43MG4","54868-2005;Synthroid;tablet;LEVOTHYROXINE SODIUM;0.075 mg;9J765S329G Q51BO43MG4","51138-171;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;300 ug;9J765S329G Q51BO43MG4","55154-0913;SYNTHROID;tablet;LEVOTHYROXINE SODIUM;88 ug;9J765S329G Q51BO43MG4","0456-1321;Levothroid;tablet;levothyroxine sodium;50 ug;9J765S329G Q51BO43MG4","51138-165;Levothyroxine Sodium;tablet;LEVOTHYROXINE SODIUM;112 ug;9J765S329G Q51BO43MG4","60793-851;Levoxyl;tablet;levothyroxine sodium;50 ug;9J765S329G Q51BO43MG4","55567-137;Novothyrox;tablet;LEVOTHYROXINE SODIUM;137 ug;9J765S329G Q51BO43MG4","60793-857;Levoxyl;tablet;levothyroxine sodium;137 ug;9J765S329G Q51BO43MG4","0781-5181;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;50 ug;9J765S329G Q51BO43MG4","55567-133;Novothyrox;tablet;LEVOTHYROXINE SODIUM;88 ug;9J765S329G Q51BO43MG4","55567-138;Novothyrox;tablet;LEVOTHYROXINE SODIUM;150 ug;9J765S329G Q51BO43MG4","0781-5182;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;75 ug;9J765S329G Q51BO43MG4","60793-852;Levoxyl;tablet;levothyroxine sodium;75 ug;9J765S329G Q51BO43MG4","60793-854;Levoxyl;tablet;levothyroxine sodium;100 ug;9J765S329G Q51BO43MG4","0781-5187;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;150 ug;9J765S329G Q51BO43MG4","55567-136;Novothyrox;tablet;LEVOTHYROXINE SODIUM;125 ug;9J765S329G Q51BO43MG4","60793-859;Levoxyl;tablet;levothyroxine sodium;175 ug;9J765S329G Q51BO43MG4","0781-5183;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;88 ug;9J765S329G Q51BO43MG4","0781-5186;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;125 ug;9J765S329G Q51BO43MG4","0781-5185;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;112 ug;9J765S329G Q51BO43MG4","60793-860;Levoxyl;tablet;levothyroxine sodium;200 ug;9J765S329G Q51BO43MG4","55567-134;Novothyrox;tablet;LEVOTHYROXINE SODIUM;100 ug;9J765S329G Q51BO43MG4","0781-5190;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;300 ug;9J765S329G Q51BO43MG4","55567-132;Novothyrox;tablet;LEVOTHYROXINE SODIUM;75 ug;9J765S329G Q51BO43MG4","60793-850;Levoxyl;tablet;levothyroxine sodium;25 ug;9J765S329G Q51BO43MG4","0781-5188;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;175 ug;9J765S329G Q51BO43MG4","0781-5184;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;100 ug;9J765S329G Q51BO43MG4","55567-140;Novothyrox;tablet;LEVOTHYROXINE SODIUM;200 ug;9J765S329G Q51BO43MG4","55567-135;Novothyrox;tablet;LEVOTHYROXINE SODIUM;112 ug;9J765S329G Q51BO43MG4","55567-130;Novothyrox;tablet;LEVOTHYROXINE SODIUM;25 ug;9J765S329G Q51BO43MG4","60793-853;Levoxyl;tablet;levothyroxine sodium;88 ug;9J765S329G Q51BO43MG4","60793-858;Levoxyl;tablet;levothyroxine sodium;150 ug;9J765S329G Q51BO43MG4","0781-5191;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;137 ug;9J765S329G Q51BO43MG4","0781-5180;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;25 ug;9J765S329G Q51BO43MG4","55567-139;Novothyrox;tablet;LEVOTHYROXINE SODIUM;175 ug;9J765S329G Q51BO43MG4","0781-5189;Levothyroxine sodium;tablet;LEVOTHYROXINE SODIUM;200 ug;9J765S329G Q51BO43MG4","60793-856;Levoxyl;tablet;levothyroxine sodium;125 ug;9J765S329G Q51BO43MG4","55567-141;Novothyrox;tablet;LEVOTHYROXINE SODIUM;300 ug;9J765S329G Q51BO43MG4","55567-131;Novothyrox;tablet;LEVOTHYROXINE SODIUM;50 ug;9J765S329G Q51BO43MG4","60793-855;Levoxyl;tablet;levothyroxine sodium;112 ug;9J765S329G Q51BO43MG4"],"TARGETS":["Thyroid hormone receptor alpha (THA_HUMAN)|Homo sapiens|~THRA~EAR7~ERBA1~NR1A1~THRA1~THRA2|P10827|A8K3B5|P21205|Q8N6A1|Q96H73","Thyroid hormone receptor beta (THB_HUMAN)|Homo sapiens|~THRB~ERBA2~NR1A2~THR1|P10828|B3KU79|P37243|Q13986|Q3KP35|Q6WGL2|Q9UD41"],"id":"OYC","ID":["OYC"]},{"Synonyms":["D thyroxin","Choloxin","Sodium dextrothyroxine","Dextrothyroxine sodique","D-tyrosine, o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate","Sodium (2r)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoate hydrate","Dextrotiroxina sodica","Dextrothyroxinum natricum","Dextrothyroxine sodium","D-t4 thyroid hormone","Dextrothyroxine","D-tyrosine, o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-"],"CompoundCID":["5819","8730","853"],"CompoundMOA":["Anticholesteremic Agents"],"REFS":["D-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051490|MeSH (Medical Subject Headings File)||--Systematic Name--","Dextrothyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051490|MeSH (Medical Subject Headings File)||--Name of Substance--","Dextrothyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051490|MeSH (Medical Subject Headings File)||--MeSH Heading--","51-49-0|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051490|PubMed Toxicology (Toxicology Citations From PubMed)||--CAS Registry Number--","Dextrothyroxine sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|EINECS (EU Inv of Exist.  Comm.  Chem  Sub)||--Systematic Name--","Choloxin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Dextrothyroxine sodique|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|NLM (National Library of Medicine)||--Synonyms--","Dextrothyroxine sodique|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|NLM (National Library of Medicine)|INN-French|--Synonyms--","Dextrothyroxine sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Dextrothyroxinum natricum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|NLM (National Library of Medicine)||--Synonyms--","Dextrothyroxinum natricum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|NLM (National Library of Medicine)|INN-Latin|--Synonyms--","Dextrotiroxina sodica|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|NLM (National Library of Medicine)||--Synonyms--","Dextrotiroxina sodica|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|NLM (National Library of Medicine)|INN-Spanish|--Synonyms--","Sodium dextrothyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","137-53-1|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|ChemIDPlus||--CAS Registry Number--","7548-09-6|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|NLM (National Library of Medicine)||--Other Registry Number--","Dextrothyroxine sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007054082|FDA SRS (FDA Substance Registration System)||--Name of Substance--","Dextrothyroxine sodium|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007054082|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|USAN:INN|--Name of Substance--","Choloxin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007054082|Drugs@FDA (FDA Drug Database)||--Synonyms--","7054-08-2|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0007054082|ChemIDPlus||--CAS Registry Number--","ClinicalTrials.gov||NCGC||","NPC informatics|NPC-9299302~Microsource:MS-1500774~Prestwick:CAS-51-48-9~Sigma - ALDRICH:MFCD00002595~Sigma - SIGMA:234702|NCGC||","FDA human approved||NCGC||","FDA approved||NCGC||","Approved drugs||NCGC||","NPC screening|NCGC00164336|NCGC||","HTS amenable drugs||NCGC||HTS amenable drugs","Human approved drugs||NCGC||","7054-08-2|DEXTROTHYROXINE SODIUM|KEGG||","137-53-1|DEXTROTHYROXINE SODIUM|Tariff||","DEXTROTHYROXINE SODIUM|DEXTROTHYROXINE SODIUM|KEGG||","Dextrothyroxine sodium|DEXTROTHYROXINE SODIUM|KEGG||","DEXTROTHYROXINE SODIUM|DEXTROTHYROXINE SODIUM|Tariff||","DEXTROTHYROXINE SODIUM|CHOLOXIN|FDA orange book||","DEXTROTHYROXINE SODIUM|CHOLOXIN|FDA drugs@FDA||","dextrothyroxinum natricum|dextrothyroxinum natricum|INN2||","137-53-1|dextrothyroxinum natricum|INN2||"],"CompoundIndication":["Antihyperlipidemic"],"CURATIONS":["||||1307010352176","Name!","null!","Dextrothyroxine!","!","Pending!"],"DATASET":["ClinicalTrials.gov","NPC informatics","KEGG","FDA human approved","FDA approved","ChemIDPlus diffs","Approved drugs","NPC screening","HTS amenable drugs","INN","FDA orange book","FDA drugs@FDA","Community curation","Tariff","Human approved drugs"],"SMILES":"N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","CAS":["51-49-0","137-53-1","7548-09-6","7054-08-2"],"CLINICALTRIALS":["NCT00565890","NCT00388297","NCT01189344","NCT00111735","NCT00498238","NCT00524238","NCT00770016"],"MOLFILE":"Dextrothyroxine\n  Marvin  11101717252D          \n\n 24 25  0  0  1  0            999 V2000\n    0.5954   -2.1656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -2.5781    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   -0.8335   -2.1656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335   -1.3406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -0.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    0.3094    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335    0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335    1.1344    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191    1.5469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    1.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3099    1.5469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.0243    1.1344    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3099    2.3719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.0243    2.7844    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    2.7844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954    3.6094    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191    2.3719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.5480   -0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.2625    0.3094    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.5480   -0.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.1191   -3.4031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.8335   -3.8156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5954   -3.8156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  1  1  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  6  7  1  0  0  0  0\n  6  8  1  0  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n 10 11  1  0  0  0  0\n 11 12  2  0  0  0  0\n 12 13  1  0  0  0  0\n 12 14  1  0  0  0  0\n 14 15  1  0  0  0  0\n 14 16  2  0  0  0  0\n 16 17  1  0  0  0  0\n 16 18  1  0  0  0  0\n 10 18  2  0  0  0  0\n  8 19  2  0  0  0  0\n 19 20  1  0  0  0  0\n 19 21  1  0  0  0  0\n  4 21  2  0  0  0  0\n  2 22  1  0  0  0  0\n 22 23  1  0  0  0  0\n 22 24  2  0  0  0  0\nM  END\n","name":"Dextrothyroxine","ID":["OYA"],"id":"OYA"},{"Synonyms":["O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine mixt. with o-(4-hydroxy-3-iodophenyl)-3,5-diiodo-l-tyrosine","Thyrolar","Thyreotom","Liotrix","Triiodothyronine - thyroxine combination","Euthroid","Liotrix (t4","Thyroxine - triiodothyronine combination","Thyroxine - triiodothyronine combination, monosodium salt","Euthyral","Choloxin","Dynothel","Eulipos","Lisolipin","Dextrothyroxine","3,5,3?,5?-Tetraiodo-d-thyronine Sodium","D-Thyroxine Sodium","Dekstrotyroksiininatrium","Dextrothyroxinum Natricum","Dextrotiroxina s�dica","Dextrotyroxinnatrium","Sodium 4-O-(4-hydroxy-3,5-di-iodophenyl)-3,5-di-iodo-d-tyrosinate hydrate","2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid"],"CompoundCID":["5819","8730","853","5920","71212","23666110","16760684","861","24867454","23687509"],"CompoundMOA":["Hormones","Dextrothyroxine is a antihyperlipidemic. The mechanism of action is not completely understood, but dextrothyroxine apparently acts in the liver to stimulate formation of low-density lipoprotein (LDL) and, to a much greater extent, to increase catabolism of LDL. This leads to increased excretion of cholesterol and bile acids via the biliary route into the feces, with a resulting reduction in serum cholesterol and LDL. Dextrothyroxine has no significant effect on high-density lipoproteins (HDL).","Inherently, it will also bind to thyroid receptors and as it is a prohormone, it will bind as a substrate to iodide peroxidase."],"REFS":["Liotrix|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|USAN|--Name of Substance--","Euthroid|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Liotrix|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Thyrolar|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","8065-29-0|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008065290|ChemIDPlus||--CAS Registry Number--","O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine mixt. with O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008061583|MeSH (Medical Subject Headings File)||--Systematic Name--","Euthyral|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008061583|MeSH (Medical Subject Headings File)||--Synonyms--","Thyreotom|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008061583|MeSH (Medical Subject Headings File)||--Synonyms--","Thyroxine - triiodothyronine combination|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008061583|MeSH (Medical Subject Headings File)||--Name of Substance--","8061-58-3|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008061583|ChemIDPlus||--CAS Registry Number--","39388-33-5|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008061583|NLM (National Library of Medicine)||--Other Registry Number--","62651-59-6|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0008061583|NLM (National Library of Medicine)||--Other Registry Number--","Thyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|CCRIS (NCI Chem Carcino  Res Info Sys)||--Systematic Name--","Thyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|USPDDN (United States Pharmacopeia Dictionary of Drug Names)|BAN|--Name of Substance--","Thyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|HSDB (Hazardous Substances Data Bank)||--Synonyms--","51-48-9|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|ChemIDPlus||--CAS Registry Number--","587-29-1|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Other Registry Number--","587-30-4|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Other Registry Number--","7200-84-2|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Other Registry Number--","74-16-8|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Other Registry Number--","7488-70-2|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051489|DART (Developmental and Reprod.Tox.)||--Other Registry Number--","25416-65-3|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0025416653|ChemIDPlus||--CAS Registry Number--","61333-06-0|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0025416653|NLM (National Library of Medicine)||--Other Registry Number--","Dextrothyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051490|MeSH (Medical Subject Headings File)||--Name of Substance--","Dextrothyroxine|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051490|MeSH (Medical Subject Headings File)||--MeSH Heading--","51-49-0|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000051490|PubMed Toxicology (Toxicology Citations From PubMed)||--CAS Registry Number--","50809-32-0|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000055038|TSCAINV (EPA Chem.  Sub.  Inventory)||--Other Registry Number--","300-30-1|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000300301|ChemIDPlus||--CAS Registry Number--","1491-91-4|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0001491914|ChemIDPlus||--CAS Registry Number--","Choloxin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Dextrothyroxinum natricum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|NLM (National Library of Medicine)||--Synonyms--","Dextrothyroxinum natricum|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|NLM (National Library of Medicine)|INN-Latin|--Synonyms--","Dynothel|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","Lisolipin|http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFullDisplay.jsp?calledFrom=lite&chemid=0000137531|RTECS (Reg.  of Toxic Eff.  of Chem.  Sub.)||--Synonyms--","ClinicalTrials.gov||NCGC||","NPC informatics|NPC-9299304~Microsource:MS-1500774~Microsource:MS-1502047~National Cancer Institute:NSC-46046~Prestwick:CAS-1823692~Prestwick:CAS-51-48-9~Sigma - ALDRICH:MFCD00002593~Sigma - ALDRICH:MFCD00002595~Sigma - SIGMA:234702~Sigma - SIGMA:T2877~Sigma - SIGMA:T67407|NCGC||","FDA human approved||NCGC||","FDA approved||NCGC||","Approved drugs||NCGC||","NPC screening|NCGC00164336|NCGC||","HTS amenable drugs||NCGC||HTS amenable drugs","DrugBank v3.0|DB00509|NCGC||","Human approved drugs||NCGC||","25416-65-3|LEVOTHYROXINE SODIUM|KEGG||","8065-29-0|LIOTRIX|KEGG||","LIOTRIX|LIOTRIX|KEGG||","Liotrix|LIOTRIX|KEGG||"],"CompoundIndication":["Thyroid","Used to lower high cholesterol levels in the blood."],"CURATIONS":["trung|NCGC|trung@jhu.edu||1307218315609","CompoundDisplay!","N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O!","NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O!","!","Pending!","trung|NCGC|trung@jhu.edu||1307213521980","URL!","null!","http://en.wikipedia.org/wiki/Thyroxine!","!","Pending!","CompoundDisplay!","NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O!","N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O!","!","Pending!","||||1307010388727","Name!","null!","Thyroxine!","!","Pending!"],"Wikipedia":["http://en.wikipedia.org/wiki/Dextrothyroxine"],"DATASET":["ClinicalTrials.gov","NPC informatics","KEGG","FDA human approved","FDA approved","Approved drugs","NPC screening","HTS amenable drugs","DrugBank v3.0","FDA orange book","FDA drugs@FDA","Community curation","ChemIDPlus diffs","Human approved drugs"],"SMILES":"NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","URL":["http://en.wikipedia.org/wiki/Thyroxine"],"CAS":["8065-29-0","8061-58-3","6106-07-6","51-48-9","587-29-1","587-30-4","7200-84-2","74-16-8","7488-70-2","25416-65-3","61333-06-0","51-49-0","50809-32-0","300-30-1","39388-33-5","62651-59-6","1491-91-4"],"CLINICALTRIALS":["NCT00565890","NCT00388297","NCT01189344","NCT00111735","NCT00498238","NCT00524238","NCT00770016"],"MOLFILE":"Thyroxine\n  Marvin  11101717252D          \n\n 24 25  0  0  0  0            999 V2000\n   -1.4568   -0.5592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.7456   -0.9770    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.4568    0.2727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.1748   -0.9700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.0277   -0.5661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.1714    0.6835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.8859   -0.5558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.0277    0.2589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6800   -0.9839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.8893    0.2727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.1714    1.5120    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -3.6039   -0.9700    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6870    0.6697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.7422    0.6731    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n    1.3981   -0.5765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6731   -1.8088    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0\n   -3.6039    0.6835    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    1.4015    0.2519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.1161    0.6559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8307    0.2451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5417    0.6524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8272   -0.5799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2563    0.2416    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5453    1.4775    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  1  3  1  0  0  0  0\n  1  4  2  0  0  0  0\n  2  5  1  0  0  0  0\n  3  6  2  0  0  0  0\n  4  7  1  0  0  0  0\n  5  8  1  0  0  0  0\n  5  9  2  0  0  0  0\n  6 10  1  0  0  0  0\n  6 11  1  0  0  0  0\n  7 12  1  0  0  0  0\n  8 13  2  0  0  0  0\n  8 14  1  0  0  0  0\n  9 15  1  0  0  0  0\n  9 16  1  0  0  0  0\n 10 17  1  0  0  0  0\n 13 18  1  0  0  0  0\n 18 19  1  0  0  0  0\n 19 20  1  0  0  0  0\n 20 21  1  0  0  0  0\n 20 22  1  0  0  0  0\n 21 23  1  0  0  0  0\n 21 24  2  0  0  0  0\n  7 10  2  0  0  0  0\n 15 18  2  0  0  0  0\nM  END\n","name":"Thyroxine","TARGETS":["Thyroid hormone receptor alpha (THA_HUMAN)|Homo sapiens|~THRA~EAR7~ERBA1~NR1A1~THRA1~THRA2|P10827|A8K3B5|P21205|Q8N6A1|Q96H73","Thyroid hormone receptor beta (THB_HUMAN)|Homo sapiens|~THRB~ERBA2~NR1A2~THR1|P10828|B3KU79|P37243|Q13986|Q3KP35|Q6WGL2|Q9UD41","Thyroid peroxidase (PERT_HUMAN)|Homo sapiens|~TPO|P07202|P09934|P09935|Q8IUL0|Q8NF94|Q8NF95|Q8NF96|Q8NF97|Q8TCI9"],"ID":["OXZ"],"id":"OXZ"},{"Synonyms":["Levothyroxine sodium anhydrous"],"REFS":["NPC informatics|NPC-9123972|NCGC||","Approved drugs||NCGC||","Structure undefined||NCGC||Structure undefined","Human approved drugs||NCGC||","Levothyroxine sodium anhydrous|Levothyroxine sodium anhydrous|UK NHS||"],"MOLFILE":"Levothyroxine sodium anhydrous\n  Marvin  11101717262D          \n\n  0  0  0  0  0  0            999 V2000\nM  END\n","name":"Levothyroxine sodium anhydrous","DATASET":["NPC informatics","Approved drugs","Structure undefined","Human approved drugs","UK NHS"],"SMILES":"","id":"EIP","ID":["EIP"]},{"Chemical Name":"D-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt","CAS":["51-49-0","137-53-1"],"Raw Materials":"3-Iodo-5-nitro-4-hydroxybenzaldehyde\n4-Methoxyphenol\nAcetaldehyde\nAcetic anhydride\nBenzenesulfonyl chloride\nBrucine\nFormic acid\nIodine\nMethylamine\nNickel Raney\nPhosphorus\nPotassium iodide\nPyridine\nSodium\nSodium nitrite","References":"Nahm H., Siedel W.; Chem. Ber.; v 96, No 1, 1-9; 1963\nNahm H., Siedel W.; D.B. Patent No. 1,067,826; Dec. 24, 1955\nSiedel W. et al.; D.B. Patent No. 1,077,673; Aug. 1958","Common Name":["Dextrothyrosine sodium","Sodium dextrothyroxine","D-Thyroxine sodium"],"UNII PT":"Dextrothyroxine sodium","id":"0H00N2AHSP","Drug Products":"eyJQcm9kdWN0IjoiQ2hvbG94aW4iLCJDb21wYW55IjoiS25vbGwifQ==\neyJQcm9kdWN0IjoiQ2hvbG94aW4iLCJDb21wYW55IjoiQWJib3R0In0=\neyJQcm9kdWN0IjoiT3JveGluZSIsIkNvbXBhbnkiOiJTaWdtYSJ9\neyJQcm9kdWN0IjoiTGV2b3RoeXJveCIsIkNvbXBhbnkiOiJNZXJjayBMaXBoYSBTYW50ZSJ9","Drug Substance":"Dextrothyroxine sodium","UNII":"0H00N2AHSP","Therapeutic Function":"Thyroid hormone, Anticholesteremic"},{"Chemical Name":"L-3,3',5,5'-Tetraiodothyronine sodium salt","CAS":["55-03-8","51-48-9"],"Raw Materials":"Acetic acid\nHydrochloric acid\nManganese sulfate\nN-Acetyl-L-diiodotyrosinamide\nSodium hydroxide","References":"Merck Index 5303\nKleeman and Engel p. 525\nPDR p. 993\nOCDS Vol. 1 p. 97 (1977) I.N. p. 558\nREM p. 980\nAnthony, P.Z. and Ginger, L.G.; US Patent 2,889,364; June 2, 1959;assigned to Baxter Laboratories, Inc.","UNII PT":"Levothyroxine Sodium","id":"9J765S329G","Drug Products":"eyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiU3ludGhyb2lkIiwiWWVhciBJbnRyb2R1Y2VkIjoiMTk1MyIsIkNvbXBhbnkiOiJGbGludCJ9\neyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiTGV0dGVyIiwiWWVhciBJbnRyb2R1Y2VkIjoiMTk2NSIsIkNvbXBhbnkiOiJBcm1vdXIifQ==\neyJDb3VudHJ5IjoiVUsiLCJQcm9kdWN0IjoiRWx0cm94aW4iLCJDb21wYW55IjoiR2xheG8ifQ==\neyJDb3VudHJ5IjoiVy4gR2VybWFueSIsIlByb2R1Y3QiOiJFdXRoeXJveCIsIkNvbXBhbnkiOiJNZXJjayJ9\neyJDb3VudHJ5IjoiSXRhbHkiLCJQcm9kdWN0IjoiRXV0aXJveCIsIkNvbXBhbnkiOiJCcmFjY28ifQ==\neyJDb3VudHJ5IjoiTm9yd2F5IiwiUHJvZHVjdCI6IkxldmF4aW4iLCJDb21wYW55IjoiTnllZ2FhcmQifQ==\neyJDb3VudHJ5IjoiRnJhbmNlIiwiUHJvZHVjdCI6Ikxldm90aHlyb3giLCJDb21wYW55IjoiTWVyY2sgQ2xldmVub3QifQ==\neyJDb3VudHJ5IjoiVHVya2V5IiwiUHJvZHVjdCI6Ikxldm90aXJvbiIsIkNvbXBhbnkiOiJBYmRpIElicmFoaW0ifQ==\neyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiUm8tVGh5cm94aW5lIiwiQ29tcGFueSI6IlJvYmluc29uIn0=\neyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiU3ludGFyb2lkIiwiQ29tcGFueSI6IlRyYXZlbm9sIn0=\neyJDb3VudHJ5IjoiVy4gR2VybWFueSIsIlByb2R1Y3QiOiJUaGV2aWVyIiwiQ29tcGFueSI6IkdsYXhvIn0=\neyJDb3VudHJ5IjoiSmFwYW4iLCJQcm9kdWN0IjoiVGh5cmFkaW4tUyIsIkNvbXBhbnkiOiJUZWlrb2t1IFpva2kifQ==\neyJDb3VudHJ5IjoiRGVubWFyayIsIlByb2R1Y3QiOiJUaHlyYXBsZXgiLCJDb21wYW55IjoiRXJjbyJ9\neyJDb3VudHJ5IjoiQXVzdHJpYSIsIlByb2R1Y3QiOiJUaHlyZXgiLCJDb21wYW55IjoiU2FuYWJvIn0=","UNII":"9J765S329G","Drug Substance":"Levothyroxine sodium","Therapeutic Function":"Thyroid hormone"},{"Chemical Name":"O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine","CAS":["6893-02-3","55-06-1"],"Raw Materials":"Iodine\nL-Diiodothyronine","References":"Merck Index 5337\nKleeman and Engel p. 527\nPDR pp. 1606, 1709\nOCDS Vol. 1 p. 97 (1977) I.N. p. 562\nREM p. 980\nPitt-Rivers, R. and Gross,J.; US Patent 2,823,164; February 11,1958;\nassigned to National Research Development Corporation, England\nPlatt, J.T. and Wenner, W.; US Patent 2,784,222; March 5, 1957; assigned to\nHoffmann-La Roche Inc.\nRazdan, R.K. and Wetherill, L.A.; US Patent 2,993,928; July 25,\n1961;assigned to Glaxo Laboratories, Ltd.","Common Name":["3,5,3'-Triiodothyronine","L-3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]alanine"],"UNII PT":"Liothyronine","id":"06LU7C9H1V","Drug Products":"eyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiQ3l0b21lbCIsIlllYXIgSW50cm9kdWNlZCI6IjE5NTYiLCJDb21wYW55IjoiU0tGIn0=\neyJDb3VudHJ5IjoiRnJhbmNlIiwiUHJvZHVjdCI6IkN5bm9tZWwiLCJZZWFyIEludHJvZHVjZWQiOiIxOTYxIiwiQ29tcGFueSI6Ik1lcnJlbGwifQ==\neyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiQ3l0b2JpbiIsIkNvbXBhbnkiOiJOb3JkZW4ifQ==\neyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiQ3l0b21pbmUiLCJDb21wYW55IjoiRGFyYnkifQ==\neyJDb3VudHJ5IjoiVVMiLCJQcm9kdWN0IjoiUm8tVGh5cm9uaW5lIiwiQ29tcGFueSI6IlJvYmluc29uIn0=\neyJDb3VudHJ5IjoiVUsiLCJQcm9kdWN0IjoiVGVydHJveGluIiwiQ29tcGFueSI6IkdsYXhvIn0=\neyJDb3VudHJ5IjoiVy4gR2VybWFueSIsIlByb2R1Y3QiOiJUaHlib24iLCJDb21wYW55IjoiSG9lY2hzdCJ9\neyJDb3VudHJ5IjoiSmFwYW4iLCJQcm9kdWN0IjoiVGh5cm9uYW1pbiIsIkNvbXBhbnkiOiJUYWtlZGEifQ==\neyJDb3VudHJ5IjoiSmFwYW4iLCJQcm9kdWN0IjoiVGh5cm9uaW5lIiwiQ29tcGFueSI6IlRhaXNobyJ9\neyJDb3VudHJ5IjoiVHVya2V5IiwiUHJvZHVjdCI6IlRpcm9tZWwiLCJDb21wYW55IjoiQWJkaSBJYnJhaGltIn0=\neyJDb3VudHJ5IjoiSXRhbHkiLCJQcm9kdWN0IjoiVGktVHJlIiwiQ29tcGFueSI6IkdsYXhvIn0=\neyJDb3VudHJ5IjoiTm9yd2F5IiwiUHJvZHVjdCI6IlRyaWpvZHRoeXJvbmluIiwiQ29tcGFueSI6Ik55ZWdhYXJkIn0=\neyJDb3VudHJ5IjoiRnJhbmNlIiwiUHJvZHVjdCI6IlRyaXRoeXJvbiIsIkNvbXBhbnkiOiJNaWxsb3QifQ==","Drug Substance":"Liothyronine","UNII":"06LU7C9H1V","Therapeutic Function":"Thyroid hormone"},{"mechanism-of-action":"The hormones, T<sub>4</sub> and T<sub>3</sub>, are tyrosine-based hormones produced by the thyroid gland. Iodine is an important component in their synthesis. The major form of thyroid hormone in the blood is thyroxine (T4). This is converted to the more active liothyronine form by deiodinases in peripheral tissues. Liothyronine acts on the body to increase the basal metabolic rate, affect protein synthesis and increase the body's sensitivity to catecholamines (such as adrenaline). The thyroid hormones are essential to proper development and differentiation of all cells of the human body. To various extents T<sub>4</sub> and T<sub>3</sub> regulate protein, fat and carbohydrate metabolism. Their most pronounced effect is on how human cells use energetic compounds. The thyroid hormone derivatives bind to the thyroid hormone receptors initially to initiate their downstream effects.","synonyms":["3,3',5-triiodo-L-thyronine","3,5,3'-Triiodo-L-thyronine","3,5,3'-Triiodothyronine","3,5,3'TRIIODOTHYRONINE","4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine","L-3,5,3'-Triiodothyronine","L-T3","Liothyronine","Liothyroninum","Liotironina","O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine","T3","Tertroxin","Tresitope","Triiodothyronine"],"pharmacodynamics":"Thyroid hormone drugs are natural or synthetic preparations containing T<sub>4</sub> or T<sub>3</sub> or both. T<sub>4</sub> and T<sub>3</sub> are produced in the human thyroid gland by the iodination and coupling of the amino acid tyrosine. Liothyronine (T<sub>3</sub>) contains three atoms of iodine and is formed by the coupling of one molecule of diiodotyrosine (DIT) with one molecule of monoiodotyrosine (MIT). These hormones enhance oxygen consumption by most tissues of the body and increase the basal metabolic rate and the metabolism of carbohydrates, lipids and proteins. Thus, they exert a profound influence on every organ system in the body and are of particular importance in the development of the central nervous system.","description":"tryptophan transport","groups":["approved","vet_approved"],"SMILES":"N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O","half-life":"2.5 days","unii":"GCA9VV7D2N","InChIKey":"AUYYCJSJGJYCDS-LBPRGKRZSA-N","drugbank-id-others":["APRD01074"],"xml":"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","name":"Liothyronine","id":"DB00279","indication":"Used as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis.","drugbank-id":"DB00279"},{"toxicity":"LD<sub>50</sub>=20 mg/kg (orally in rat). Hypermetabolic state indistinguishable from thyrotoxicosis of endogenous origin. Symptoms of thyrotoxicosis include weight loss, increased appetite, palpitations, nervousness, diarrhea, abdominal cramps, sweating, tachycardia, increased pulse and blood pressure, cardiac arrhythmias, tremors, insomnia, heat intolerance, fever, and menstrual irregularities.","mechanism-of-action":"Levothyroxine acts like the endogenous thyroid hormone thyroxine (T<sub>4</sub>, a tetra-iodinated tyrosine derivative). In the liver and kidney, T<sub>4</sub> is converted to T<sub>3</sub>, the active metabolite. In order to increase solubility, the thyroid hormones attach to thyroid hormone binding proteins, thyroxin-binding globulin, and thyroxin-binding prealbumin (transthyretin). Transport and binding to thyroid hormone receptors in the cytoplasm and nucleus then takes place. Thus by acting as a replacement for natural thyroxine, symptoms of thyroxine deficiency are relieved.","synonyms":["3,3',5,5'-Tetraiodo-L-thyronine","3,5,3',5'-TETRAIODO-L-thyronine","4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine","L-T4","L-Thyroxine","Levothyroxin","LT4","O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine","O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine","T4"],"pharmacodynamics":"Levothyroxine (T<sub>4</sub>) is a synthetically prepared levo isomer of thyroxine, the major hormone secreted from the thyroid gland. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine (T<sub>3</sub>) which exerts a broad spectrum of stimulatory effects on cell metabolism. Thyroid hormone increases the metabolic rate of cells of all tissues in the body. In the fetus and newborn, thyroid hormone is important for the growth and development of all tissues including bones and the brain. In adults, thyroid hormone helps to maintain brain function, food metabolism, and body temperature, among other effects. The symptoms of thyroid deficiency relieved by levothyroxine include slow speech, lack of energy, weight gain, hair loss, dry thick skin and unusual sensitivity to cold.","description":"tryptophan transport","groups":["approved"],"SMILES":"N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","half-life":"T<sub>4</sub>, 6 to 7 days. T<sub>3</sub>, 1 to 2 days.","unii":"054I36CPMN","InChIKey":"XUIIKFGFIJCVMT-LBPRGKRZSA-N","drugbank-id-others":["APRD00235","EXPT02993"],"route-of-elimination":"Thyroid hormones are primarily eliminated by the kidneys.","xml":"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","name":"Levothyroxine","metabolism":"Approximately 70% of secreted T<sub>4</sub> is deiodinated to equal amounts of T<sub>3</sub> and reverse triiodothyronine (rT<sub>3</sub>), which is calorigenically inactive. Elimination of T<sub>4</sub> and T<sub>3</sub> involves hepatic conjugation to glucuronic and sulfuric acids. The hormones undergo enterohepatic circulation as conjugates are hydrolyzed in the intestine and reabsorbed. Conjugated compounds that reach the colon are hydrolyzed and eliminated as free compounds in the feces. Other minor T<sub>4</sub> metabolites have been identified. ","id":"DB00451","indication":"For use alone or in combination with antithyroid agents to treat hypothyroidism, goiter, chronic lymphocytic thyroiditis, myxedema coma, and stupor.","drugbank-id":"DB00451"},{"toxicity":"Symptoms of dextrothyroxine overdose are unknown.","mechanism-of-action":"Dextrothyroxine is a antihyperlipidemic. The mechanism of action is not completely understood, but dextrothyroxine apparently acts in the liver to stimulate formation of low-density lipoprotein (LDL) and, to a much greater extent, to increase catabolism of LDL. This leads to increased excretion of cholesterol and bile acids via the biliary route into the feces, with a resulting reduction in serum cholesterol and LDL. Dextrothyroxine has no significant effect on high-density lipoproteins (HDL).\r\nInherently, it will also bind to thyroid receptors and as it is a prohormone, it will bind as a substrate to iodide peroxidase.","synonyms":["D-T4","D-thyroxine","Dextrothyroxine","DT4","O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine"],"pharmacodynamics":"Dextrothyroxine, the dextrorotary isomer of the synthetic thyroxine, is a antihyperlipidemic.","description":"tryptophan transport","groups":["approved"],"SMILES":"N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O","unii":"0H00N2AHSP","InChIKey":"XUIIKFGFIJCVMT-GFCCVEGCSA-N","drugbank-id-others":["APRD00911"],"xml":"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","name":"Dextrothyroxine","id":"DB00509","indication":"Used to lower high cholesterol levels in the blood.","drugbank-id":"DB00509"},{"toxicity":"Hypermetabolic state indistinguishable from thyrotoxicosis of endogenous origin. Symptoms of thyrotoxicosis include weight loss, increased appetite, palpitations, nervousness, diarrhea, abdominal cramps, sweating, tachycardia, increased pulse and blood pressure, cardiac arrhythmias, tremors, insomnia, heat intolerance, fever, and menstrual irregularities.","mechanism-of-action":"The hormones, T<sub>4</sub> and T<sub>3</sub>, are tyrosine-based hormones produced by the thyroid gland. Iodine is an important component in their synthesis. The major secreted form of thyroid hormone is T4. T4 is converted T3, the more active thyroid hormone, by deiodinases in peripheral tissues. T3 acts in the body to increase basal metabolic rate, alter protein synthesis and increase the body's sensitivity to catecholamines (such as adrenaline). Thyroid hormones are essential for proper development and differentiation of all cells of the human body. T<sub>4</sub> and T<sub>3</sub> regulate protein, fat and carbohydrate metabolism to varying extents. The most pronounced effect of the hormones is in altering how human cells use energetic compounds. The thyroid hormone derivatives bind to the thyroid hormone receptors initially to initiate their downstream effects.","synonyms":["Levothyroxine sodium - liothyronine sodium mixt","Liotrix (T4;T3)"],"pharmacodynamics":"Thyroid hormone drugs are natural or synthetic preparations containing T<sub>4</sub> or T<sub>3</sub> or both. T<sub>4</sub> and T<sub>3</sub> are produced in the human thyroid gland by the iodination and coupling of the amino acid tyrosine. Liotrix is a synthetic preparation of T4 and T3 in a 4:1 weight-based ratio. These hormones enhance oxygen consumption by most tissues of the body and increase the basal metabolic rate and the metabolism of carbohydrates, lipids and proteins. Thus, they exert a profound influence on every organ system in the body and are of particular importance in the development of the central nervous system.","description":"small molecule metabolic process","groups":["approved"],"SMILES":"[Na+].[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C([O-])=O.N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O","unii":"YW8HJ0N26X","InChIKey":"LKYWLLWWYBVUPP-XOCLESOZSA-L","route-of-elimination":"Thyroid hormones are primarily eliminated by the kidneys.","xml":"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","name":"Liotrix","id":"DB01583","indication":"May be used to treat primary, secondary or tertiary hypothyroidism. May also be used to suppress thyroid stimulating hormone (TSH) secretion in patients with simple (nontoxic) goiter, subacute or chronic lymphocytic thyroiditis multinodular goiter, and in the management of thyroid cancer. May be used in conjunction with other antithyroid agents to treat thyrotoxicosis to prevent goitrogenesis and hypothyroidism. May also be used for differential diagnosis of suspected mild hyperthyroidism or thyroid gland autonomy.","drugbank-id":"DB01583"},{"InChIKey":"AUYYCJSJGJYCDS-UMVFHIKJSA-N","synonyms":["Liothyronine I 131"],"xml":"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","name":"Liothyronine I-131","description":"This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.","groups":["investigational"],"SMILES":"N[C@@H](CC1=CC([131I])=C(OC2=CC([131I])=C(O)C=C2)C([131I])=C1)C(O)=O","id":"DB12425","drugbank-id":"DB12425","unii":"86AZ0G22V2"}]}